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Coronary heart disease is a leading cause of death in the United States, totaled mostly by 
deaths associated with myocardial infarction and fatal ventricular arrhythmias. The inability to 
predict the occurrence of these pathologies due to their sudden and transient etiologies has 
hindered successful translation of therapies to the clinic. Given the multi-billion-dollar economic 
burden that cardiovascular disease exerts, it would be beneficial to further our knowledge on 
ways to better treat acute coronary syndromes. The goal of this work is to determine how 
mitochondria impact cardiac ischemia/reperfusion (I/R) injury, and to identify potential 
mechanisms to therapeutically target. The studies within were conducted on treadmill-trained 
male rats, ex vivo heart preparations, isolated/cell cultures, and isolated mitochondria. Herein 
demonstrates a strong link between susceptibility to I/R injury and cardioprotection through the 
manipulation of mitochondrial thiol status. Hearts from exercised rats were better protected from 
ischemic insults, and this coincided with preserved thiol redox homeostasis and greater stability 
in mitochondrial bioenergetics. The maintenance of mitochondria thiol was demonstrated 
through preservation of glutathione, which is a key redox control point in cardiac bioenergetics. 
When the thiol pool becomes more oxidized following oxidative stress, loss of mitochondrial 
membrane potential and collapsed bioenergetics increase susceptibility to I/R injury. Glutathione 
reductase helps maintain cell redox homeostasis by maintaining glutathione in a reduced form, 
where it can be utilized in ROS scavenging and redox signaling. In cell models of 
hypoxia/reoxygenation, targeting glutathione reductase expression influences the cells 
  
sensitivity to mitochondrial dysfunction. Several hallmark features of the cardioprotective 
phenotype include reductions in myocardial infarction, resistance to arrhythmic stimuli, lower 
ROS accumulation, and preserved mitochondrial function. Taken together, data from the studies 
suggest that targeting mitochondrial function during I/R, and more specifically, targeting 
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Chapter 1: Introduction 
 
 
Prevalence and economic burden of cardiovascular disease 
Cardiovascular disease (CVD) remains one of the leading causes of death in North 
America, and although rates of death attributable to cardiovascular disease have declined in 
recent years, the burden of disease remains high (94). It is estimated that 85.6 million American 
adults have one or more types of cardiovascular disease, with coronary heart disease (CHD) 
making up more than half of all cardiovascular events in men and women <75 years of age 
(151). The indirect cost for all CVD is projected to increase from $202.5 billion to $308.2 billion 
between 2013 and 2030; a 52% increase in costs, and CHD is projected to account for ≈43% of 
the increase. Furthermore, CHD accounts for ≈50% of deaths that are attributed to CVD (Figure 
1). Given the high prevalence and economic burden of CHD in the American population, there is 
a need for improved therapeutic interventional strategies targeting acute coronary syndromes. 
Figure 1. Breakdown of deaths attributable to CVD in the United States (2013). 
46.20%  Coronary Heart Disease
16.10%  Stroke
8.10%  Heart Failure
9.00%  High Blood Pressure
3.20%  Diseases of the Arteries
17.40%  Other
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Acute coronary syndromes and ischemia/reperfusion (I/R) injury increases the risk of myocardial 
infarction and arrhythmia (152), and will be the main focus of this dissertation.  
Ischemia/Reperfusion injury in cardiac pathology 
The heart demands a constant supply of energy due to its high metabolic activity and 
contractile function. Cellular energetic homeostasis is critical for normal cardiac physiology and   
when the heart becomes ischemic due to temporary or permanent occlusion of coronary arteries 
the cells energy stores become depleted (e.g. adenosine triphosphate (ATP) levels fall). Upon 
the onset of ischemia, mitochondrial oxidative phosphorylation decreases with the fall of cellular 
oxygen tension, leading to an increase in anaerobic metabolism and decrease in cellular pH.  
After longer duration ischemia, the depletion of energy stores and accumulation of 
intracellular protons leads to altered ATP-dependent channel regulation. Sarcolemmal ATP-
sensitive potassium (KATP) channels conduct an inward rectifying potassium current and contain 
ATP regulatory subunits. When ATP levels fall, sarcolemmal KATP channel open probability 
increases, allowing potassium to move down its concentration gradient and leave the cell. The 
accumulation of potassium in the extracellular space coupled with accumulation of intracellular 
sodium and calcium leads to altered action potential duration, and reduced cellular excitability. 
The decrease in ATP and altered ion homeostasis sets the stage for subsequent reperfusion 
injury.  
In acute coronary syndromes the duration of ischemia is the most important variable as 
an independent predictor of infarct size (99). Therefore, prompt restoration of blood flow to the 
ischemic tissue is critical. This was emphasized in a recent meta analysis that found higher 
short-term mortality in ST-segment elevation myocardial infarction (STEMI) patients who 
presented off hours and had longer door-to-balloon times for percutaneous coronary 
intervention (PCI) (199).  
 
   
3 
 Paradoxically, subsequent reperfusion of previously ischemic tissue exacerbates 
cardiac injury and accelerates tissue necrosis (110). Although the etiology of reperfusion injury 
is multifactorial, the generation of ROS upon the restoration of oxygen has been identified as a 
central mediator of reperfusion injury 
(26, 70, 150, 237). Several lines of 
evidence implicate mitochondria as 
central hubs for the generation of ROS 
during reoxygenation, as well as targets 
that mediate the downstream injury 
response (5, 225). To this end, targeting   
mitochondria therapeutically has come to the forefront in cardioprotective paradigms reaching 
clinical trials, and a schematic of candidate mechanisms is provided in Figure 2.    
Mitochondria in health and disease 
Mitochondrial bioenergetics is critical in maintaining energy homeostasis in cardiac 
tissue. Carbon substrates and intermediary metabolism of nutrients consumed in the diet 
provides reducing equivalents in the form of nicotinamide adenine dinucleotide (NADH) and 
flavin adenine dinucledotide (FADH2). Oxidation of these reducing equivalents by the electron 
transport system (ETS) is coupled with proton pumping into the inter-membrane space, thereby 
generating an electro-chemical gradient across the inner-mitochondrial membrane. The electro-
chemical gradient is mostly comprised of the mitochondrial membrane potential (ΔΨm), and ATP 
synthase utilizes the release in free energy to replenish cellular ATP through oxidative 
phosphorylation under increasing energetic demand.  
Tight coupling of cardiac supply-demand matching allows for normal cardiac physiology. 
However, during metabolic stress, ROS production can induce oscillations in ΔΨm and collapse 
Figure 2. Mitochondrial therapies recently investigated in 
clinical studies to reduce myocardial infarction. 
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mitochondrial energetics (8, 161). When mitochondrial bioenergetics are compromised, cellular 
ATP levels fall, which can lead to sarcolemmal KATP channel opening and altered ion flux across 
the sarcolemmal membrane. As mentioned previously, sarcolemmal KATP channel opening leads 
potassium efflux and heterogeneity in cardiac action potential duration. Altered synchronicity of 
cardiac electrical activity is an arrhythmic substrate for the genesis of re-entrant ventricular 
arrhythmias (153, 161). Thus, oxidative stress and altered redox homeostasis is intimately 
linked with the stabilization of mitochondrial energetics. 
Targeting thiol redox stress in cardioprotection 
During I/R injury, ATP demand matching by the mitochondria falters, leading to adverse 
cardiac outcomes. However, cellular ATP hydrolysis is not the only system that operates in an 
“energetic” fashion. Thiol redox stress during metabolic insults, such as cellular 
hypoxia/reoxygenation (6), also requires energy as nicotinamide nucleotide transhydrogenase 
(NNT) utilizes ΔΨm for reduction of NADPH and oxidation of NADH. Reduced glutathione 
(GSH), thioredoxin (Trx), NADPH, and NADH provide ROS buffering through enzyme mediated 
oxidation and reduction reactions (11, 90). These buffering systems are important links that 
integrate mitochondrial energetics and redox homeostasis (121). In cardiac myocytes a ROS-
induced ROS release phenomenon has been described a mediator of mitochondrial 
permeability transition pore (PTP) opening (235). More recent studies demonstrate cross talk 
between mitochondrial thiol, ROS production, and mitochondrial membrane potential (ΔΨm) 
oscillations and depolarization (8, 198). The precise mechanism that links thiol redox stress with 
a collapse in mitochondrial energetics is not completely clear. However the two mitochondrial 
channels implicated in oxidative-stress induced mitochondrial dysfunction are the inner 
membrane anion channel (IMAC) and the mitochondrial permeability transition pore (PTP) 
(236). Both of which play prominent roles in mediating I/R injury. 
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Understanding exercise cardioprotection for therapeutic development 
 Exercise is a well-characterized cardioprotective model that is highlighted by enhanced 
antioxidant capacity. The cardioprotective mechanisms that trigger exercise-induced 
cardioprotection are thoroughly reviewed in Chapter 2. The adaptive phenotype ultimately 
reduces thiol stress during I/R, helping to preserve cardiac electrical synchrony as well as tissue 
necrosis (80). Redox biology in medicine has yet to reach its full potential as we have only 
reached the tip of the iceberg in our understanding of redox chemistry in a cellular context. 
Compartmentalization only increases the complexity of studying this phenomenon. And while 
the benefits to exercise are clear, the 2014 National Health Interview Survey data indicated only 
half of American adults met the current aerobic physical activity guideline, and that even this 
number is likely substantially overestimated according to self-reported physical activity studies 
(151). Therefore, a better understanding of cardioprotective models implicated in redox biology 
would be beneficial for the development of future therapies. 
Central Hypothesis 
The goal of this dissertation is to advance our understanding of cardiac mitochondria in 
I/R injury. The central hypothesis is that preservation of redox homeostasis during I/R injury 
minimizes the mitochondrial dysfunction and bioenergetic collapse mediated by ROS 
accumulation and thiol redox stress. Therapies aimed at preserving thiol redox homeostasis or 
stimulating enhanced redox control may prove beneficial in reducing acute coronary syndromes. 
This dissertation covers areas on how thiol redox homeostasis is linked to cardiac disease 
pathogenesis (Chapter 3), mechanisms involved in regulating redox homeostasis and 
mitochondrial function (Chapter 4), and how exercise-induced adaptations alter post-ischemic 
mitochondrial function (Chapter 5). 
 
 
Chapter 2: Why does exercise “trigger” adaptive protective responses in the heart? 
From Alleman RJ, Stewart LM, Tsang AM, Brown DA. Why does exercise “trigger” adaptive 




The beneficial effects of exercise on the cardiovascular system have been well 
characterized over the last several decades and it is now accepted that exercise can be used as 
primary prevention for cardiovascular disease (162). Manifestations of cardiovascular disease 
are blunted with exercise in experimental animal models, and epidemiological data in humans 
further support these findings (95, 217). Exercise-induced protection against acute coronary 
syndromes encompasses a reduction in myocardial infarction (35, 80, 129), arrhythmia (80, 81), 
and stunning (27, 131, 206, 207). While there is an abundance of literature on proposed 
mechanisms that seek to explain the protective effects of exercise (129, 202), a large portion of 
this research focuses on end points of protection as well as the downstream signaling events 
that protect the myocardium.  
During exercise, an increase in cardiac output is warranted so that the heart can meet 
the demands of exercising muscles. Aside from matching cardiac output with peripheral blood 
supply, exercise also induces preconditioning whereby the heart is more resistant to injury even 
long after the exercise has ceased. The proverbial “triggers” that induce cardioprotective 
signaling are clearly multi-factorial, and include neural, endocrine, and paracrine factors, as well 
as autocrine signaling and adaptations that arise from within the heart itself.  
Exercise can be thought of as eustress; positive stress that a cell responds to in a way 
that allows it to better cope with that stressor. The adaptive mechanisms associated with 
 
   
7 
exercise ultimately induce a cardioprotective phenotype, resulting in increased endogenous 
defenses against longer duration stressors (i.e. ischemia). Proposed triggers of exercise 
cardioprotection include: adenosine, opioids, adenosine monophosphate-activated protein 
kinase (AMPK), cytokines, mitochondrial and cytosolic derived reactive oxygen species (ROS), 
nitric oxide (NO), and adrenergic signaling. This review will focus on studies investigating 
cardioprotection induced by acute aerobic exercise regimens (i.e. days, weeks, and months of 
training) at moderate to high intensity. The windows of protection include an early window that 
occurs within the first hour after exercise, and a late window that typically lasts from 24 to 72 
hours (33, 227). Studies that utilize different exercise regimens or include protection outside of 
these time points will be described in detail. We will start by briefly discussing epidemiological 
findings in humans pertaining to exercise duration and disease risk prevention, and then shift 
the focus to the various biological compounds that are responsible for cardioprotection. The 
main objective herein is to provide a review of the literature addressing the adaptive response to 
exercise that triggers the phenotypic-cardioprotective switch with different doses of exercise, 
and to shed light on gaps in the literature that may be hindering our understanding of exercise 
cardioprotection.  The first half of our review will focus on circulating factors released during 
exercise that converge on the heart, and the latter portion of the review will focus on adaptations 
that occur within the heart during exercise.   
What dose of exercise is needed for cardioprotection? 
Although there are benefits of exercise across intensities, both epidemiological and 
animal studies suggest that moderate to high-intensity exercise is best for the heart.  The dose-
response aspect relating the quantity of exercise that results in a reduction in cardiovascular risk 
has been extensively investigated across a number of human epidemiological studies. In a 
longitudinal study Lee et al. tracked physical activity in 482 males (average 66 years of age) 
over a five year period and showed that energy expenditure was the key variable in reducing 
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coronary heart disease risk (128). They found shorter intervals of exercise at a higher intensity 
provides the same protective benefit as longer intervals of exercise at a lower intensity, as long 
as the overall energy expenditures were equal. The study also supports the idea that exercise 
intensity is an important determinant of cardioprotection following an acute exercise regimen 
(e.g. days to weeks), and that multiple small bouts of intense exercise may have the same net 
result as one extended bout of exercise. Mora et al. investigated differing levels of physical 
activity in a group of 27,055 healthy women, determined by kcal/wk expended (149). They 
showed a dose-dependent relationship with 200-599, 600-1499 and >1500 kcal/wk groups 
having a 27%, 32% and 41% reduction in cardiovascular disease risk respectively compared to 
the baseline group which expended less than 200 kcal/wk. Although the authors acknowledged 
more research was necessary to determine the exact biological mechanisms that resulted in this 
protection, they found that the reduction in risk seen with increasing levels of physical activity 
can be explained in large part by a reduction in inflammatory/hemostatic biomarkers. These 
findings provide evidence for systemic adaptations with chronic physical activity that contributes 
to reductions in cardiovascular mortality, which are multifactorial with extrinsic and intrinsic 
cardiac adaptations. 
In animal studies, cardioprotection from I/R injury has been shown to occur after only a 
single bout of exercise and is sustainable if the exercise continues for many months (reviewed 
in (79, 175)). The majority of our focus herein is on factors released during exercise itself. Long-
term chronic exercise is likely a combination of acute factors (reaping the benefits of each 
individual exercise session) and adaptations that include shifted autonomic nervous system 
activity, heightened levels of cardioprotective proteins (described below), and beneficial 
hypertrophy. In terms of acute exercise, cardioprotection (reductions in myocardial infarction) is 
observed after moderately high-intensity exercise (>70% VO2 max) (33, 84, 104, 178, 227), 
consistent with the notion that higher intensity appears to be the most beneficial for the heart. In 
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the following sections, we will describe the different factors released during exercise that initiate 
the protective phenotypic shift.   
Adenosine 
Adenosine is a purine nucleoside molecule that has been identified as a trigger of 
exercise-induced adaptations within the myocardium. Signaling occurs through four cell-surface 
receptors distributed heterogeneously throughout regions of the myocardium: adenosine A1, 
A2A. A2B, and A3 receptors (83). Adenosine receptor activation signals through G-protein coupled 
receptors (Gi, Gs, Go, and Gq) leading to the targeting of various downstream effectors and 
divergent regulation of cardiac function (44). During exercise, cardiac adenosine levels rise 
proportional to increasing heart rate (219). A potential interplay between heart rate and 
adenosine release in exercise cardioprotection was demonstrated in dogs where the infarct 
salvage observed following intermittent bouts of tachycardia was abolished with administration 
of an adenosine receptor blocker (66). Support for the cardioprotective effect of adenosine is 
also provided in non-exercise, non-I/R studies whereby treatment with adenosine leads to the 
activation of endogenous antioxidant defense systems, and the adenosine receptor antagonist 
theophylline abolishes this effect (107, 138). Similarly, adenosine receptor blockade during 
exercise exacerbates post-exercise oxidative stress biomarkers (107). Taken together, these 
findings indicate that the increase in heart rate during exercise leads to a transient oxidative 
stress which is blunted through adenosine-induced upregulation of the antioxidant defense 
system. However the intermediate signaling of adenosine that may be responsible for triggering 
exercise cardioprotection is less well defined. Non-exercise studies suggests that A1 receptor 
activation reduces infarct size by priming the opening of mitochondrial potassium adenosine 
triphosphate (mitoKATP) channels, presumably through a PKC mediated mechanism (187). One 
study demonstrated that opening of mitoKATP channels may play a role in the early phase of 
exercise cardioprotection, as the early window of protection was abolished with channel 
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blockade during exercise (65). However, exercise-induced mitoKATP channel activity has not 
been linked to adenosine signaling and merits further research before conclusions can be 
drawn. Therefore, these results suggest that transient increases in adenosine levels are 
important for ROS buffering during acute exercise, but whether or not this is due to opening of 
mitoKATP channels is not known. While cardiac adenosine signaling following exercise seems to 
be important for the activation of redox networks, adenosine has not been established as being 
solely responsible for the increase in antioxidant capacity. In addition it is also unknown if 
adenosine receptor blockade during consecutive exercise bouts would mitigate the upregulation 
in antioxidant defense systems.  
One of the limitations in our understanding of adenosine as a trigger for exercise 
cardioprotection is the lack of knowledge pertaining to the specificity of adenosine receptor 
activation following exercise. As mentioned previously, there are four different adenosine 
receptors, and the specific subtypes activated following exercise has not been well 
characterized. For example, pharmacological blockade of adenosine receptors with theophylline 
is thought to inhibit signaling through A1 and A2A receptors (109). Theophylline is commonly 
used as an adenosine receptor blocker (66, 107), but the specificity of their action and the 
downstream signaling events has not been tested in exercise-preconditioning studies. The use 
of non-specific pharmacological compounds is problematic from a mechanistic standpoint 
because adenosine receptor activation elicits divergent effects depending on the subtype of 
receptors activated. Further, adenosine receptors possess the ability to dimerize with other 
subtypes (83), leading to greater complexity in the biological actions of adenosine. Nonetheless, 
adenosine appears to exert a substantial effect on cardiac physiology and pathophysiology, but 
more research is needed to solidify adenosine as a required trigger for exercise 
cardioprotection.  
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Opioids 
Opioids are another cell-surface signaling molecule that can trigger a protective 
phenotype. Endorphins, enkephalins, and dynorphins predominately signal through μ-, δ-, and 
κ-opioid receptors respectively, each with various subtypes distributed centrally and peripherally 
(211). Pharmacological activation of κ- and δ-opioid receptors reduces infarct size, with a 
‘second window of preconditioning’ similar to what is seen with exercise (85, 190). Opioid-
mediated signaling occurs throughout the nervous system, and there is evidence that striated 
muscle can produce preproenkephalin mRNA and peptide products (200, 221).  
Several studies have examined opioids following exercise.  A ten-fold increase in overall 
serum opioid activity immediately following exhaustive exercise has been observed in human 
(179, 191) and rodent models (60), with release of various endorphins being most prominent 
following high-intensity exercise (>90% VO2 max). These data are particularly interesting from a 
dose-response standpoint, as the opioid release occurred following near-maximal exercise, and 
many studies find benefit after a sub-maximal exercise regimen (32, 36, 41, 79, 171, 175, 208).  
Further support for the role of opioids in exercise-induced cardioprotection comes from 
studies examining blood-borne factors. Michelsen et al. recently observed infarct size reductions 
in isolated rabbit hearts that were perfused with human plasma dialysates conditioned by acute 
high-intensity exercise. Co-perfusion with a non-specific opioid antagonist reduced the infarct 
sparing effect (147), which is consistent with other studies where pre-exercise administration of 
the non-specific opioid antagonist naloxone/naltrexone abolished protection afforded by a 12-
week exercise regimen (63, 86). 
Like adenosine mediated protection, there is evidence that opioid signaling also acts 
through the mitoKATP channel. In non-exercise studies, protection observed following opioid 
receptor activation is abolished with the mitoKATP blocker 5-HD (Fryer et al. 1999). 
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Administration of 5-HD prior to I/R also abolishes the anti-arrhythmic effect of exercise, but 
opioid levels were not measured (178). However, unlike adenosine-mediated protection, opioid 
signaling may not exert its protective effects through the upregulation of antioxidant defense 
systems. Twenty-four hours after a five-day exercise regimen, mRNA levels of opioid precursors 
and receptors increased in unstressed hearts while there was no change in superoxide 
dismutase, HSPs, and catalase (63). Even though these specific antioxidant gene transcripts 
did not change, enhanced ROS buffering cannot be ruled out because antioxidant capacity was 
not comprehensively analyzed. Although we are still early in our understanding of how opioids 
are influencing exercise cardioprotection, these preliminary studies provide rationale for their 
release and biological activity following exercise.   
Cytokines 
Cytokine production during exercise is another putative triggering mechanism of 
exercise cardioprotection that has received less attention from the scientific community. During 
exercise contracting muscle acts as an endocrine organ by secreting various cytokines that can 
facilitate downstream biological actions (67). In non-exercise studies, early work demonstrated a 
cardioprotective role for cytokines in I/R injury that involved lower oxidative stress during the 
reperfusion period (37, 72). Subsequent studies by Yamashita et al. sought to determine how 
exercise-induced cytokine production influenced infarct salvage (227). They demonstrated that 
administration of TNF-α and IL-1 antibodies prior to a single exercise bout abolished the early- 
and late-windows of cardioprotection. However, aside from the cardioprotective effects that 
cytokines can exert on the myocardium, there are deleterious effects as well. The discrepant 
findings in the literature regarding adverse and cardioprotective actions of cytokines on I/R has 
been reviewed (185). The cardioprotective action of cytokines appears to occur at lower 
concentrations, whereas higher concentrations may exert harmful effects. Moving forward more 
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research is needed to uncover the divergent roles of cytokines on myocardial physiology before 
they can be implemented as therapeutic agents for I/R injury.  
Adrenergic Signaling 
The role of adrenergic receptor stimulation during exercise has become recognized as a 
part of exercise-induced cardioprotection. In response to systemic demand, β-adrenergic 
stimulation increases cardiac chronotropy, inotropy and lusitropy (reviewed in (203)). These 
effects are mainly attributed to the β1-adrenergic receptor which is the predominant isoform in 
the heart, but β3-adrenergic receptors appear to play a contradictory role, as stimulation leads to 
a negative inotropic response (156, 205). The negative inotropic effect is mediated through 
downstream activation of eNOS (89). However, the existence of a functional β3-adrenergic 
receptor in the human heart has recently been called into question due to the lack of selectivity 
of pharmacological tools used to study its function and expression (reviewed in (146)). 
Nonetheless, it has been postulated that β-adrenergic stimulation may trigger exercise 
cardioprotection by increasing NO bioavailability. β-adrenergic stimulation of cardiac tissue via 
the sympathetic nervous system has been shown to be important in triggering the protective 
phenotype, as ablation of the cardiac sympathetic nerve with topical application of phenol 
abolishes the infarct salvage afforded by seven days of exercise in mice (4). The authors 
attributed these effects to a decrease in eNOS activity because an increase in eNOS 
phosphorylation was not observed in mice with cardiac sympathetic nerve ablation, but was 
increased with exercise alone. Interestingly, the transient oxidative stress observed with 
exercise was also absent with cardiac sympathetic nerve ablation, indicating interplay between 
adrenergic stimulation, NO, and ROS in exercise cardioprotection. In another study Calvert et 
al. also demonstrated that adrenergic receptors play an important role in exercise 
cardioprotection via interaction with the NOS isoforms (42).  Plasma catecholamine and β3-
adrenergic receptor density increased following four weeks of voluntary wheel running, with no 
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changes in the β1 and β2 isoforms. The cardioprotection against myocardial infarction observed 
in the voluntary wheel running mice was abolished in β3-adrenergic receptor deficient mice. 
Similar to the previous study that linked adrenergic signaling to increased eNOS 
phosphorylation, eNOS phosphorylation as well as cardiac NO metabolites were depressed in 
β3-adrenergic receptor deficient mice exposed to voluntary wheel running. These findings 
implicate adrenergic signaling as a triggering mechanism during exercise. In this regard, Calvert 
et al. demonstrated that a single epinephrine bolus increased eNOS phosphorylation and heart 
NO metabolites. Importantly, infarct salvage following voluntary wheel running was lost when 
NO metabolites returned to normal levels after four weeks of exercise cessation. Taken 
together, there is strong evidence for a role of adrenergic signaling in the triggering phase of 
exercise cardioprotection and the subsequent upregulation of NO bioavailability. However, more 
research is needed to fully characterize the specific role of β3-adrenergic receptor stimulation in 
NOS activation, especially in light of the fact that β2-adrenergic receptor activation has also 
been shown to be cardioprotective and can increase eNOS activity and NO metabolites (18). 
Nitric Oxide 
NO was initially thought to act only through local mediation of vasodilation due to its 
short half-life and high reactivity with biological substrate (134), however more recent work 
implicates NO in downstream  mechanisms distant from the site of production (41, 49, 73), as 
well as in cardiac myocytes themselves (reviewed in (23)). During exercise, blood flow and 
vascular shear stress are elevated in tissue beds with high metabolic activity, which leads to the 
activation of endothelial nitric oxide synthase (eNOS) and heightened release of NO (17, 193, 
217, 231). NO metabolites such as nitrite, nitrate, and nitrosothiols were once thought of as 
inert, but are now widely accepted as storage forms of NO that undergo inter-conversion to 
exert biological effects (39, 41, 220, 238). In non-exercise studies, the molecular reduction of 
nitrite to NO and nitrosothiols during I/R is cardioprotective (38, 49, 220), which indicates that an 
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increase in NO bioavailability may be an important determinant of exercise-induced 
cardioprotection.  
Following exercise, there is an increase in eNOS activation and NO metabolites (4, 41), 
and when eNOS is genetically knocked out, the infarct sparing effects after seven days of 
exercise is abolished (4). The study also demonstrated that the upregulation of eNOS during 
exercise was necessary for the subsequent increased activity of inducible NOS (iNOS) and the 
downstream infarct sparing effect of exercise (4). Others have observed an increase in iNOS 
activity following an acute bout of exercise, and when an iNOS inhibitor was administered prior 
to I/R the antiarrhythmic effect of exercise was abolished (15). However, the role of iNOS in 
exercise cardioprotection has been called into question due to the interspecies variability in 
expression patterns and a lack of increase following various exercise regimens (41, 174). More 
recently Farah et al. demonstrated a role for eNOS in exercise cardioprotection in rats after five 
weeks of training (73). Following the exercise regimen phosphorylation of eNOS was increased 
in the exercise group, as well as s-nitrosylated proteins and nitrite. Perfusion with a global NOS 
inhibitor prior to and immediately after I/R abolished the infarct sparing and mechanical recovery 
observed with exercise.  They also demonstrated that eNOS uncoupling during the reperfusion 
period was required for the cardioprotection. However, not all groups demonstrate an essential 
role for NO in exercise cardioprotection. Taylor et al. administered a global NOS inhibitor prior to 
two days of exercise with the idea that cardioprotection would be lost. However, the beneficial 
effects of exercise on mechanical recovery and LDH release after I/R in rats were not different 
than with exercise alone (207). The main difference in these studies is the timing of NOS 
inhibition (before exercise vs before I/R), and the duration of the exercise regimen. The study by 
Taylor et al. provides evidence against a role for NO production during exercise as a triggering 
mechanism for cardioprotection. However, NO production during exercise may not be 
responsible for cardioprotection per se, rather the increase in NO bioavailability and increase in 
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eNOS activation (phosphorylation) seems to be more important in the cardioprotective 
phenotype. A mechanism whereby NO production can increase after exercise has been 
demonstrated. Following acute exercise, circulating bradykinin levels increase (21), stimulating 
the production of NO and NO metabolites (234). Furthermore, bradykinin has been 
demonstrated to mediate its anti-arrhythmic effects through liberation of NO during I/R (212). 
Given the discrepant findings, a few questions are left that need to be addressed moving 
forward. What is the locus of NO production that leads to an increase in NO metabolites 
(endothelium vs cardiac myocytes), what are the temporal characteristics of NO production 
during and/or following exercise, and when precisely does the cardioprotective phenotype 
become evident?  In response to the latter, most studies indicate that storage forms of NO 
precipitate their cardioprotective effects during reperfusion. Clearly more work is needed to 
definitely determine the role of NO production during/after exercise and how this affects NO 
metabolite accumulation en route to cardioprotection. 
Adenosine Monophosphate-Activated Protein Kinase 
Cardiac myocytes are densely packed with mitochondria in order to support cellular 
energetic requirements. In the healthy heart, the heightened rate of ATP hydrolysis during 
exercise increases mitochondrial respiration, ultimately allowing healthy myocytes to efficiently 
match ATP generation to cardiac workload. While cellular ATP:ADP ratios remain constant, 
AMP levels are thought to rise with increasing exercise intensity, leading to the activation of 
AMPK in cardiac muscle (55, 82). In this context, the activation of AMPK stimulates catabolic 
processes and down regulates anabolism allowing the cell to regulate metabolism for the 
production of ATP (55). AMPK has been deemed as one of the energy sensors of the cell and 
its activity increases by phosphorylation within 10 minutes of the onset of moderate and high 
intensity exercise (55). AMPK has also been shown to be important in post-ischemic cardiac 
injury, with exacerbated injury in transgenic mice expressing a dominant negative kinase dead α 
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subunit of AMPK (183). Canonical AMPK signaling increases glucose and lipid oxidation, which 
is essential for replenishing ATP following an ischemic period.  
In addition to increasing catabolism, AMPK has been shown to play a role in ischemic 
preconditioning by regulating sarcolemmal KATP channel trafficking and activity (204). These 
studies suggest an important role for AMPK activity following ischemia/reperfusion (I/R), but the 
extent to which AMPK influences exercise cardioprotection has received less attention. 
Although studies have consistently shown that exercise increases the phosphorylation of AMPK 
(55, 163), AMPK has not been shown to be crucial for exercise adaptations. Similar levels of 
exercise can be attained in transgenic mice expressing a cardiac-specific dominant-negative 
AMPKα2 subunit (155). Following 30 minutes of exercise, transgenic mice had similar cardiac 
glycogen and ATP levels as wild-type controls. A similar metabolic profile between the wild type 
and transgenic mice indicates that AMPK may not be crucial for enhanced cardiac metabolism, 
and that other overlapping pathways can help meet energy requirements during increased 
demand. Although AMPK is an attractive target for the cell to regulate its energy needs during 
metabolic stress, there is a gap in the literature linking exercise-induced AMPK activation with 
cardioprotection. More research is required to definitively determine if/how exercise influences 
AMPK activity in the heart, and whether or not these changes modify cardioprotection. 
Reactive Oxygen Species 
Cardiac ROS are another potential candidate involved in exercise cardioprotection, as 
well as other preconditioning stimuli such as ischemic and pharmacological preconditioning 
(88). A large body of literature suggests that exercise induces a transient oxidative stress that 
leads to upregulation in antioxidant defense systems; however the locus of ROS production and 
downstream effectors during exercise remains unclear. In this section we will focus on evidence 
for the role of mitochondrial ROS in exercise cardioprotection, and cytosolic ROS in the 
following section.  
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ROS have received considerable attention in the cardiac literature due to their role in 
pathologies like I/R injury, heart failure, and cardiomyopathies. However, a growing body of 
literature suggests that ROS exert hormesis, where transient bursts of ROS leads to favorable 
adaptive redox signaling. Cellular ROS can act as second messengers in downstream signaling 
by altering the activity of redox sensitive enzymes throughout the cytosol and/or mitochondria of 
cardiac myocytes (184). Similar mechanisms may occur when transient bursts of ROS are 
generated during exercise. (24, 59, 97). Following acute exercise there is an alteration in 
cellular redox status towards a more oxidized environment which may act as a signal to activate 
endogenous protective mechanisms (80, 157).  
There is general consensus that an increase in antioxidant enzymes is responsible for a 
large portion of exercise cardioprotection, and transient oxidative stress with exercise may play 
a role in this adaptation. Evidence for this has been provided by several groups who have 
observed increases in key antioxidant enzymes following exercise (61, 80, 81, 96, 129, 178, 
227). Studies in favor of this hypothesis have shown that administration of antioxidants prior to 
exercise abolishes infarct salvage (4, 227) and prevents exercise-induced improvements in 
cardiac performance (157). However, another study indicated that ROS generated during 
exercise were not required for functional recovery following I/R (208). The antioxidant frequently 
used in these studies was N-(2-mercaptopropionyl)glycine) (MPG), which was administered 
intraperitoneally 10-30 minutes prior to exercise. An important note to consider is that MPG has 
been shown to have higher specificity for hydroxyl radicals rather than hydrogen peroxide 
(H2O2) and superoxide (25), indicating that not all ROS signaling is abolished with treatment. In 
addition, MPG has a plasma half-life of approximately 7 minutes (103), making it difficult to 
interpret how effective the treatment was at scavenging ROS during hour-long exercise bouts. 
These methodological differences make it difficult to directly compare their results (i.e. 
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differences in species, duration of I/R, duration of exercise, measurement of injury, the timing of 
the administration of antioxidants, and in vivo versus ex vivo experiments).  
Mitochondrial ROS.  ROS signaling is a highly regulated and localized process, implying that the 
origin of ROS generated during exercise may be extremely important. Although mitochondrial 
ROS are thought to play a central role in ischemic preconditioning (16, 124, 166), there is a 
paucity of evidence suggesting a role in exercise preconditioning. Frasier et al. recently found 
that the locus of ROS production during exercise is not mitochondrial in origin (80). As shown in 
Figure 3, exercise cardioprotection was not lost when administering agents that reduce 
mitochondrial ROS prior to exercise (mito TEMPO and Bendavia). This indicates that 
extramitochondrial-derived ROS may be responsible for redox signaling following exercise.  
Monoamine oxidase-A (MAO-A) is another potential site for mitochondrial ROS 
production. MAO-A is located on the outer mitochondrial membrane and catalyzes the oxidative 
deamination of neurotransmitters such as norepinephrine and serotonin while generating H2O2 
Figure 3. Reductions in infarct size are abolished by inhibiting NADPH Oxidase (with pre-exericse treatment 
of apocynin or VAS2870) during exercise. Inhibition of mitochondrial ROS during exercise (with pre-exercise 
administration of TEMPO or the mitochondria-targeting peptide Bendavia) had no effects on exercise 
cardioprotection. Figure reproduced from Frasier et al., Cardiovascular Research 2013, with permission (pending). 
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as a byproduct in the reaction. A recent review highlights the importance of MAO-A in 
pathological states such as heart failure and I/R (116). Accumulation of serotonin released by 
platelets during I/R can lead to the production of H2O2 and subsequent apoptotic signaling 
cascades (19).  Recent findings indicate that exercise leads to down-regulation MAO-A (119), 
which may play a role in the attenuation of I/R damage associated with exercise 
cardioprotection. Moreover, these findings indicate that there is likely a reduction in 
mitochondrial ROS production with exercise, given the decrease in MAO-A expression and 
increases in the activity of key antioxidants such as MnSOD and glutathione reductase (GR) 
(80, 178). A decrease in cardiac mitochondrial MAO-A would theoretically dampen the oxidative 
burden imposed on the cell, not only during exercise, but also during thrombus formation and 
subsequent I/R injury. A mechanism for the decrease in MAO-A expression following exercise 
has not been investigated and therefore the triggering event for this adaptation is purely 
speculative. Perhaps acute increases in cardiac sympathetic nerve stimulation and increasing 
norepinephrine levels during exercise play a role in downstream silencing of MAO-A through 
non-canonical adrenergic pathways (215). Cardiac sympathetic stimulation increases 
contractility and myocardial stretch during exercise, which in and of itself may trigger a 
cardioprotective phenotype through elevated cytosolic ROS production (80, 218). Furthermore, 
cardiac sympathetic nerve ablation has been shown to abolish the infarct sparing effect of 
exercise, but this was not linked to silencing of MAO-A expression (4). A hypothetical 
adrenergic/MAO-A axis scenario opens up an exciting area of research to explore mechanisms 
controlling MAO-A expression in cardiac tissue during normal physiological as well as 
pathophysiological states. We will further expand on the topic of stretch-induced activation of 
cardioprotection in the next section.  
Cytosolic ROS.  Free-radical generating enzyme systems outside of the mitochondria have also 
received considerable interest in normal physiology as well as in pathological states such as I/R 
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injury (24, 144, 148) and heart failure (98, 210). Sources of extramitochondrial-derived ROS in 
cardiac myocytes include xanthine oxidase, NADPH oxidase, and uncoupled nitric oxide 
synthase. Of these, the NADPH oxidase (NOX2 in particular) complex generates ROS in a 
highly localized manner in the sarcolemmal and t-tubule membranes during physiological 
stretch (172, 186). Myocardial contraction and wall stress increases during exercise as a 
function of heart rate and adrenergic signaling. The increased inotropic and chronotropic state is 
an autoregulatory mechanism that allows for tight regulation of blood pressure and delivery of 
nutrients to metabolically active tissue. Recent work indicates that the sarcolemmal NOX2-
generated ROS system plays a central role in this phenomenon. NOX2-generated ROS 
imposes redox signaling through ryanodine receptors leading to increased calcium release and 
subsequent contractile activity (68, 186). Stretch induction through the microtubule network and 
NOX2 activation has been termed X-ROS signaling (172). X-ROS signaling describes the 
transfer of a mechanical to a chemical signal throughout the heart via the microtubule system, 
leading to assembly of the NOX2 ROS generating complex. Recently, several independent 
groups have established a role for NOX2 as a potential trigger for the cardioprotective 
phenotype associated with exercise (80, 186).  
As mentioned previously, a critical threshold of exercise intensity appears to be 
important for cardioprotection, and at higher exercise intensities myocardial contraction 
increases in conjunction. In line with the X-ROS signaling hypothesis, increased inotropy and 
myocardial stretch during exercise may lead to activation of NOX2 and perhaps downstream 
adaptations. We and others have demonstrated that inhibition of NOX2 prior to exercise 
abolishes the infarct salvage of early and late phases of exercise cardioprotection (80, 186). 
Furthermore, the upregulation of GR activity that is typically observed following exercise (81, 
115, 180, 213) is also abolished immediately and 24 hours after the exercise bout when NOX2 
is inhibited during exercise (80). GR is a central enzyme involved in cellular redox control by 
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utilizing NADPH to convert oxidized glutathione to the reduced form. Therefore, increasing GR 
activity allows the cell to maintain the glutathione pool in the reduced state, thus providing a 
greater buffering power during oxidative insults. During an exercise bout, mechanical stretch of 
the myocardium increases, leading to NOX2-generated ROS and activation of GR (80). ROS 
signaling through GR may be a mechanism where GR acts as a sensor during oxidative shifts of 
the redox environment, leading to upregulation of endogenous defense systems. Future studies 
examining the time frame of GR activation and sustainability of protection will shed light on 
signaling between NOX2 and GR during the cardioprotective window of exercise. Also, studies 
that determine the importance of GR compartmentalization, namely whether cytosolic and/or 
mitochondrial GR pools are involved in this adaptive signaling network (118). While it seems 
apparent that exercise upregulates redox buffering capacity, more research is needed to 
definitively determine if transient bursts of ROS during exercise act as a signal to trigger 
downstream cardioprotection. 
Conclusions  
We have described a number of circulating and intrinsic factors postulated to induce 
cardioprotective signaling with exercise. These factors converge on the myocardium, and result 
in downstream adaptations that characterize the protective phenotype. Subsequent 
investigation into these downstream effects using novel approaches will greatly advance the 
field. For example, ROS production during exercise is an intriguing factor that leads to both 
post-translational modifications to existing proteins in the short-term, as well as altered protein 
expression on a longer time-scale. Given that 21,000 to 42,000 thiols in the proteome can 
contribute to the integration of metabolic function through redox signaling (112), further 
exploration of the redox hypothesis in the context of exercise adaptations is warranted. The 
convergent effects of cellular ROS production and elevated levels of cell-signaling molecules 
such as adenosine, NO, cytokines, and catecholamines during elevated workloads transduce 
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the exercise stimulus that culminates into a hormetic cardiac response. Inhibition of any one of 
these putative triggers can dampen the cardioprotective phenotypic switch observed with 
exercise, but ultimately, these adaptations lead to tolerance to I/R injury characterized by lower 
arrhythmia and decreased myocardial infarction. Given that exercise is known to confer 
protection in humans, future studies that continue to advance our understanding of the intrinsic 
factors responsible for evoking this protective phenotype may ultimately pave the way for novel 
therapies to reduce the burden of acute coronary syndromes. 
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Cardiovascular disease remains a leading cause of death in the industrialized world (94, 
158). One manifestation of cardiovascular disease is sudden cardiac death, which has been 
estimated to account for approximately 1 death per 1000 in the general population (78). Several 
factors are known to influence the susceptibility to arrhythmia, including various genetic 
abnormalities, channelopathies, compromised autonomic function, left ventricular hypertrophy, 
and acute coronary syndromes (78, 159, 216). During acute coronary syndromes, the 
reperfusion of previously ischemic tissue leads to a burst in reactive oxygen species (ROS), a 
significant contributor to electromechanical dysfunction (3, 26, 141, 237).  
Exercise is known to protect against arrhythmia (81, 105, 178), as well as other post-
ischemic damage such as myocardial stunning (27, 132, 207) and infarction (32, 80, 176, 177). 
Despite the clear beneficial effect, the underlying cellular mechanisms are not completely 
understood. The high oxidative environment during reperfusion collapses mitochondrial 
energetics and alters cardiac action potential duration, which is known to be arrhythmogenic (3, 
8, 9, 31). Among their many functions, mitochondria are centrally involved in both ATP 
production and free radical detoxification through redox reactions, both of which ultimately rely 
on mitochondrial membrane potential (ΔΨm).  Collapses in ΔΨm are known to be associated with 
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the onset of arrhythmia, and pharmacological interventions that preserve ΔΨm have been shown 
to stabilize sinus rhythm (31, 198). Whether the preservation of ΔΨm is an endogenous 
adaptation involved in exercise-induced protection has never been determined.  
We recently observed that exercise delayed the onset of arrhythmia and decreased the 
incidence of ventricular fibrillation (VF) through better preservation of redox homeostasis (81). 
This was attributed to enhanced glutathione reductase (GR) activity, which was essential for 
cardioprotection (80). While exercise-induced cardioprotection has been repeatedly shown to 
augment endogenous myocardial antioxidant capacity (80, 81, 129, 178, 227), there is a lack of 
evidence demonstrating how these adaptations directly protect against reperfusion arrhythmia. 
Therefore, the objective of the present study was to determine if exercise decreases reperfusion 
arrhythmia by preserving mitochondrial bioenergetics. Using several different experimental 
models, we employed a vertically integrated approach to test the hypothesis that exercise 
protects against reperfusion arrhythmia via better maintenance of ΔΨm, lower mitochondrial 
ROS production, and preserved redox homeostasis. 
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Methods    
Animals    
Male Sprague Dawley rats (250-350 g) were housed on a 12-hour light/dark cycle with 
food and water provided ad libitum. All experiments were conducted in accordance with 
guidelines established by the NIH (2012 edition) and the AVMA (2013 
Edition:https://www.avma.org/KB/Policies/Documents/euthanasia.pdf), and approved by East 
Carolina University’s Animal Care and Use Committee. For all experiments rats were 
anesthetized using a ketamine/xylazine mixture (90mg/kg ketamine, 10mg/kg xylazine, i.p.), and 
hearts were excised via midline thoracotomy after animals reached a surgical plane of 
anesthesia. Hearts were placed briefly in 0.9% saline (4ºC) and used for isolated heart studies, 
myocyte isolations, or mitochondrial experiments.   
Exercise protocol    
Rats were randomly assigned to exercise (Ex) or sedentary (Sed) groups and exposed 
to daily exercise or control handling using established protocols (81). Briefly, rats were 
acclimated to the treadmill at 15 m/min over a 3-day period, increasing the time of exercise from 
5, 10, and 15 min each day. Ex rats underwent 10 days of consecutive treadmill running at 6% 
grade for 60 min per day, in intervals broken up to 15 m/min for 15 min, 30 m/min for 30 min, 
and 15 m/min for 15 min. Sed rats were placed on the non-moving treadmill for 5 min each day. 
This exercise protocol mimics a moderate- to high-intensity exercise regimen, characterized by 
training adaptations with little/no indication of systemic stress (34). All experiments were 
performed 24 hours after the last bout of exercise or handling. 
Isolated heart preparation and assessment of arrhythmia     
Excised hearts were rapidly cannulated by the aorta per our established methods (80, 
81) and retrograde-perfused on a modified Langendorff apparatus with gassed (95%O2, 
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5%CO2) Krebs Henseleit buffer (KHB) containing (mM): 118 NaCl, 24 NaHCO3, 4.8 KCl, 2 
CaCl2, 1.2 MgSO4, 1.2 KH2PO4, and 10 glucose (37ºC), at a constant pressure of 75 mmHg. 
Coronary flow was monitored throughout the protocol with a Transonic flow probe connected in 
series proximal to the cannula. All measurements were recorded on Lab Chart 7.0 software 
(A.D. Instruments) and stored on a personal computer for subsequent analysis. The definition of 
ventricular arrhythmia was used in accordance with the methods described by the Lambeth 
Convention (58).  
Two-photon microscopy whole heart imaging during ischemia/reperfusion     
Using slight modifications of our previous techniques (31), instrumented hearts (n=18) 
were imaged using two-photon microscopy (Olympus FV 1000 multiphoton microscope; 
Spectra-Physics Maitai Deepsee laser) with a 30X silicon objective lens (UPLSAPO, NA 1.05). 
Hearts were mounted in a 100mm glass-bottom dish (MatTek) maintained at 37ºC for imaging, 
with ECG obtained via volume-conductance recordings using electrodes placed in the bath. 
Hearts were enclosed by an on-board incubator maintained at 37ºC and imaged at a depth of 
800nm. 640x640 pixel resolution images were obtained each minute at 2μs/pixel with low laser 
power (6.5%) for the duration of the protocol. The left ventricle was imaged within 2mm of the 
left anterior descending coronary artery on the MatTek dish and stabilized by applying a glass 
coverslip over the heart to minimize artifacts induced from vibrations.  
 Isolated hearts were loaded with 100nM tetramethylrhodamine methyl ester (TMRM; 
Molecular Probes, Inc.) for 15 min to measure ∆Ψm per our established methods (31). Our 
preliminary experiments showed this concentration of TMRM to be optimal in order to observe 
collapses in ∆Ψm with the mitochondrial uncoupler carbonyl cyanide-4-(trifluoromethoxy)-
phenylhydrazone (FCCP). TMRM was excited at 800nm and emission collected at 495-540nm 
using a 2-channel filter cube (FV10-MRG/R). After TMRM loading hearts were perfused with 
KHB+blebbistatin (10μM) to inhibit contraction. Once the image stabilized, a baseline image 
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was captured and followed immediately by global, no-flow ischemia/reperfusion (40 min/10 min). 
To control for unequal fluorophore loading, TMRM fluorescence was normalized to baseline (F0; 
prior to ischemia). All images were analyzed using ImageJ, and mean TMRM fluorescence was 
calculated after thresholding to exclude background for areas not containing sheets of 
myocardial cells. Four hearts were excluded from the imaging analysis due to technical 
difficulties during image acquisition (Sed n=2 and Ex n=2).  
Glutathione levels in cardiac tissue following Langendorff ischemia/reperfusion  
 Reduced glutathione (GSH) and glutathione disulfide (GSSG) were measured using high 
performance liquid chromatography (HPLC) (74, 93, 117). Left ventricular cardiac tissue was 
snap frozen in liquid nitrogen after 20 min ischemia and 2 hours of reperfusion in a subset of 
rats. Left ventricular tissue was homogenized in a buffer containing 50mM Trizma base 
supplemented with 20mM boric acid, 20mM L-serine and 10mM N-ethylmaleimide (NEM).  NEM 
is an alkylating agent that will both conjugate GSH and inhibit GR, which is added to the 
homogenization buffer to limit auto-oxidation effects during sample preparation.  The tissue 
homogenate is then split into two derivatization pathways for the detection of GSH and GSSG.  
For GSH derivatization, 280μl of the homogenate was deproteinated with 1:10 (v/v) 15% 
trichloroacetic acid, and then centrifuged for 5 minutes at 20,000xg.  The supernatant was 
transferred to an autosampler vial for processing in the HPLC equipment.  GSH samples were 
run on freshly made mobile phase containing 91% of a 0.25% (v/v) glacial acetic acid mixed 
with 9% pure HPLC grade acetonitrile.  Samples were run using a Shimadzu Prominence HPLC 
system equipped with a Premier C18 column (4.6 x 150mm. 5μm, Shimadzu Part # 220-91199-
12) at flow rate of 1.0ml/min.  GSH-NEM conjugate was detected by UV chromatography at a 
wavelength of 265nM (Shimadzu SPD-20A) (93). Samples were quantified using standards 
prepared under identical conditions and normalized to the protein content measured in the 
muscle homogenate by BCA assay. 
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 For GSSG derivatization, 200μl of the homogenate was deproteinized in 200ul 15% 
perchloric acid, and then centrifuged for 5 minutes at 20,000xg.  The resulting supernatant 
(200μl) was next diluted in 1000μl of 0.1M NaOH twice to ensure proper pH (~12) is reached 
before reacting with 0.1% 0-phthaladehyde (OPA).  OPA will react with GSSG at high pH (~12) 
to form a fluorescent product detectable at excitation/emission wavelengths 350/420 (Shimadzu 
RF-20A xs) (117). GSSG samples were processed using a 25mM sodium phosphate buffer 
containing 15% HPLC grade methanol at pH of 6. Samples were run through a Shimadzu 
Prominence HPLC system equipped with a Purospher STAR RP-18 endcapped column (4.6 x 
150mm. 3μm, EMDmillipore) at flow rate of 0.5ml/min.  Samples were quantified using 
standards prepared under identical conditions and normalized to the protein content measured 
in the muscle homogenate by BCA assay. 
Cardiac myocyte cell isolation   
Cardiac ventricular myocytes were isolated using previously published methods with 
slight modifications (30). Hearts were digested enzymatically on a modified Langendorff 
apparatus using 1mg/ml collagenase (Type 2 Worthington) and 0.15 mg/ml protease (type XIV 
Sigma) dissolved in Tyrodes solution. After 8-12 min of digestion, hearts were cut down, minced 
in Tyrodes solution, and passed through a nylon mesh filter. Cells were allowed to gravity 
precipitate and resuspended in Tyrodes with increasing titrations of calcium up to a final 
concentration of 1.8 mM. Isolated myocytes were incubated (95% O2, 37°C) in DMEM and used 
for experiments within 8 hours of dispersion.  
Cardiac myocyte imaging during hypoxia/reoxygenation      
Myocytes were loaded on a perfusion chamber housed on the confocal microscope 
stage and enclosed in glass to minimize oxygen diffusion from room air. The chamber was 
connected to an in-line solution heater that delivers the superfusate via laboratory tubing with 
low oxygen permeability (Tygon F-4040-A), and equipped with heating filaments for 
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maintenance at 37°C. Pacing electrodes were utilized for field stimulation for the duration of the 
hypoxia/reoxygenation protocol (4-ms duration, 1-Hz frequency, 10-V amplitude). Myocytes 
were perfused with Tyrodes solution gassed with 100% O2 containing (in mM): 140 NaCl, 10 
HEPES, 5 KCl, 1 MgCl2, 1.8 CaCl2, and 10 glucose (pH 7.4, 37°C). For hypoxic Tyrodes 
solution, glucose was excluded, the solution was gassed with 100% argon continuously, and the 
pH was decreased to 6.5 in an attempt to mimic the in vivo cellular environment during 
ischemia. 
 Myocytes were incubated for 15 min with TMRM (10nM) and CellTracker Blue CMAC 
(1μM) (Molecular Probes, Inc.) for fluorescent imaging of ∆Ψm and cellular GSH, respectively. 
CellTracker Blue CMAC is a GSH sensitive dye that has been shown to have better cell 
retention than monochlorobimane in primary cardiac myocytes (122). Myocytes were incubated 
on a glass coverslip coated with poly-d-lysine and allowed 15 min to adhere, followed by 5 min 
of baseline perfusion. Only rod-shaped myocytes that responded to field stimulation were 
utilized in the experiments. Preliminary control experiments indicated that a low concentration of 
TMRM (5nM) in the Tyrodes solutions was required to maintain a stable fluorescent signal for 
the duration of the protocol. After 5 min of baseline perfusion, the solution was switched to the 
hypoxic Tyrodes solution. After 20 min of hypoxia the superperfusate was switched back to 
normoxic Tyrodes for reoxygenation (30 min or until cell death). At the end of each experimental 
protocol myocytes were perfused with the mitochondrial uncoupler FCCP (1μM) to verify 
mitochondrial TMRM specificity. A 60X water immersion objective lens was used to image 
myocytes every minute using 408nm and 559nm argon lasers, and emissions were collected 
using a 430-470 and 575-675 band pass filter, respectively. Images were analyzed with NIH 
ImageJ (http://imagej.nih.gov) in 8-bit following background subtraction (rolling ball radius 50) 
with regions of interest drawn around individual cells.  NIH “Fire” and “Blue” look-up tables 
(LUTs) were used for all ∆Ψm and GSH images respectively. 
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Mitochondria isolation    
 Cardiac mitochondria were isolated from Ex or Sed hearts twenty-four hours following 
the last exercise bout (or handling) using similar previously published methods (197). Briefly, 
hearts were excised and minced on ice and trypsin-digested in mitochondria isolation medium 
(MIM) containing (in mM): 300 sucrose, 10 sodium-HEPES, and 1 EGTA. After 2 min of 
digestion, 10 ml of MIM with BSA (1mg/ml), and trypsin inhibitor (100 mg/ml) was added and 
allowed to gravity pellet for 8 min. The digested tissue was then homogenized and centrifuged 
at 800xg for 10 min. Supernatant was collected and centrifuged at 12,000xg for 10 min to pellet 
mitochondria. The pellet was rinsed to remove debris and impurities, suspended in fresh MIM 
and centrifuged at 12,000xg for 10 min. The final pellet was re-suspended in MIM and kept on 
ice for experiments.  
Mitochondrial O2 consumption and H2O2 emission measurements   
 Rates of O2 consumption (JO2) and H2O2 emission (JH2O2) were measured 
simultaneously using the Oroboros high-resolution respirometry oxygraph-2k equipped with a 
custom-made stopper to accommodate a fiber-optic cable for fluorescence measurements 
(Fluoromax 3, HORIBA Jobin Yvon, Edison, NJ, USA). Mitochondria were energized using 
complex I and complex II substrates: glutamate (10mM), malate (2mM), pyruvate (2mM), and 
succinate (5mM), and assayed at 37°C in 2.5 ml of Buffer Z assay medium containing (mM): 
110 K-Mes, 35 KCl, 1 EGTA, 5 K2HPO2 , 3 MgCl2-6H2O, 0.5 mg/ml 
 BSA, and 25 creatine 
monohydrate. The rate of H2O2 emission was quantified using Amplex UltraRed (25μM) and 
horseradish peroxidase (4U/mL), added to the assay buffer. Exogenous superoxide dismutase 
(SOD, 30U/mL) was added in order to convert all generated superoxide to H2O2. The 
hexokinase/2-deoxyglucose  (2U/mL/5mM) “ADP clamp” was used to mimic in vivo conditions. 
These conditions keep mitochondria in a submaximal phosphorylating state at a fixed ∆Ψm by 
recycling ATP back to ADP (75μM) (229). Anoxia was “self-induced” for 25 min by allowing 
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mitochondria to consume all of the O2 in the chamber. Following anoxia, mitochondria were 
reoxygenated by injecting pure O2 into an air bubble above the solution in the chamber. The 
chamber was then sealed allowing for JO2 and JH2O2 to be measured during the reoxygenation 
phase.  
The contribution of thioredoxin reductase (TrxR) or GR to mitochondrial ROS production 
was ascertained in parallel experiments.  Mitochondria were energized with succinate (10mM) 
and treated with either 1μM auranofin (AF) or 100μM bis-chloroethylnitrosourea (BCNU) to 
inhibit the thioredoxin and glutathione redox buffering systems, respectively. Endogenous 
mitochondrial ROS production was monitored as described above.   
Statistics   
 Data are presented as mean ± standard error. Arrhythmia analysis was performed using 
a chi-square test. Mean fluorescence during reperfusion and respiratory control ratios were 
analyzed using unpaired Student’s t-test. Imaging data were analyzed with an ANOVA for 
reperfusion or reoxygenation using the least significant difference test for matched time 
comparisons between Ex and Sed. All JO2 and H2O2 data were analyzed using a two-way 
ANOVA with Tukey’s post-hoc test. Statistical significance was established when P<0.05. All 
data were analyzed and graphed using GraphPad Prism software. 
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Results   
Exercise decreases arrhythmia and preserves ΔΨm during ischemia/reperfusion 
Hearts from Ex rats experienced a significantly decreased incidence of ventricular 
arrhythmia, with 33% of Ex hearts vs 88% of Sed hearts transitioning to ventricular tachycardia 
(VT) and/or fibrillation (VF) during early reperfusion (P<0.05, n=8 per group, Figure 4A). In our 
two-photon studies, non-ischemic control hearts showed a stable TMRM fluorescent signal 30 
minutes following TMRM loading, indicating that TMRM washout was not a major contributor to 
declines in the TMRM signal (data not shown). There was no difference in TMRM signal during 
ischemia between groups (Figure 4B). However, Ex hearts better maintained ΔΨm than Sed 
Figure 4. Arrhythmia and simultaneous two-photon imaging of mitochondrial membrane potential (ΔΨm) 
in isolated hearts during ischemia/reperfusion. (A) The percentage of Ex and Sed hearts that transitioned to 
arrhythmia (VT/VF) following 40 min of ischemia. (B&C) Baseline TMRM fluorescence (ΔΨm) values were used to 
normalize all data (F/F0) during ischemia (B) and reperfusion (C). (D) Representative images of ΔΨm in the 
ventricular free-wall and simultaneous ECG recordings during reperfusion for Sed and Ex. Data are shown as % 
of population for arrhythmia and mean ± SEM for all other data, n=7-8 per group. * p<0.05 vs Sed; # p<0.05 vs 
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hearts over the course of reperfusion, which coincided with a decrease in arrhythmia (P<0.05, 
Figure 4). The transition to arrhythmia in Sed hearts was often accompanied by loss of ΔΨm, 
which was better preserved in Ex hearts that did not transition to arrhythmia during the 
reperfusion period  (Figure 4D).  
Underscoring the importance of 
maintaining ΔΨm during reperfusion, pooled data 
for all hearts (regardless of Sed vs Ex group) 
corroborated the association between ΔΨm loss 
and electrical dysfunction, with maintenance of 
ΔΨm associated with protection against arrhythmia 
(Figure 5).   
Glutathione and ΔΨm dynamics 
  In cardiac myocytes exposed to in vitro 
hypoxia/reoxygenation (H/R) (20 min/30 min), 
myocytes from Ex hearts maintained higher 
levels of GSH during reoxygenation and 
showed an enhanced ability to replenish GSH 
levels compared to Sed (Figure 6A and B). In a 
more quantitative approach, GSH was 
































































A B Figure 5. Mitochondrial membrane potential 
(ΔΨm) in isolated hearts that transitioned to 
arrhythmia vs no arrhythmia during 
reperfusion. (A) ΔΨm was was better 
maintained in hearts that did not transition to 
arrhythmia. (B) Mean ΔΨm fluorescence values 
during reperfusion. Data are mean ± SEM * 
p<0.05 vs Arrhythmia; # p<0.05 vs Arrhythmia 
main effect. 








































































Figure 6. Cardiac glutathione (GSH) during cellular 
hypoxia/reoxygenation or cardiac 
ischemia/reperfusion. (A) Representative primary 
cardiac myocyte fluorescent images for Sed and Ex 
during baseline, at the end of hypoxia, and 6 minutes 
into reoxygenation. (B) Quantification of glutathione 
levels as measured by CellTracker Blue fluorescence. 
(C) HPLC quantification of reduced (GSH) and 
oxidized (GSSG) glutathione in hearts following 
ischemia/reperfusion. Data are shown as mean ± 
SEM, * p<0.05 vs Sed; # p<0.05. vs Sed main effect. 
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measured in whole hears exposed to ischemia/reperfusion injury (Figure 6C). GSH was 
significantly higher in Ex hearts (Figure 6C), further demonstrating adaptive maintenance of 
redox control following a hypoxic or ischemic insult. The attenuated GSH replenishment in Sed 
cardiac myocytes coincided with collapse of ΔΨm during reoxygenation, while the enhanced 
ability of Ex cardiac myocytes to replenish GSH translated into ΔΨm stability during 
reoxygenation (Figure 6 and 7). There was a slight decrease in ΔΨm during hypoxia as shown in 
Figure 7B, particularly during late hypoxia, but ΔΨm depolarization was more evident during 
reoxygenation, which is consistent with our observations in whole heart experiments. The time-
lapse images of ΔΨm in paced myocytes exposed to H/R were consistent with the whole heart 
two-photon data demonstrating more energetically stable mitochondrial networks in Ex hearts.  
 
Rates of mitochondrial O2 consumption and H2O2 emission during hypoxia/reoxygenation  
The quality of mitochondria was similar between the groups following isolation as 
assessed by the RCR (Sed 5.1± 0.4 vs Ex 5.2± 0.1). JO2 at a submaximal ADP (75μM) 




































Figure 7. Mitochondrial membrane potential (ΔΨm) during cardiac myocytes hypoxia/reoxygenation (H/R). (A) 
Representative images of Sed and Ex cardiac myocytes during H/R. Depolarized mitochondrial networks and 
collapses in ΔΨm are shown during reoxygenation as a transition in color from yellow to red and black. (B) 
Quantification of TMRM fluorescence during H/R. Data are shown as mean ± SEM. # p<0.05 vs Sed main effect. 
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concentration was not different between Ex and Sed mitochondria prior to anoxia when respiring 
on complex I and II substrate (Figure 8A). The decrement in JO2 immediately following anoxia 
was blunted in mitochondria from Ex animals (p<0.05, Figure 8B). Baseline state 3 JH2O2 was 
not different between Ex and Sed before the onset of anoxia (Figure 8C). JH2O2 was
significantly higher following A/R compared to pre-A/R values only for Sed mitochondria (p<0.05 
vs Sed baseline), while Ex attenuated this increase and was significantly lower than Sed 
following A/R (p<0.05 vs Sed reox, Figure 8C). Post-A/R JH2O2:JO2 was significantly higher 


















































































































































TrxR inhibition GR inhibition
Figure 8. Reactive oxygen species (ROS) and isolated mitochondrial energetics during anoxia/reoxygenation 
(A/R). Sed is gray and Ex is black in all graphs.  O2 consumption rate (JO2) and H2O2 emission rate (JH2O2) was 
measured in isolated mitochondria from Sed and Ex hearts. (A) JO2 was similar at baseline between Ex and Sed 
isolated mitochondria respiring on glutamate + malate, pyruvate, and succinate, and ADP clamped at 75 μM (state 3). 
(B) Impairments in state 3 JO2 following A/R was determined by comparing relative decreases from baseline for Sed 
and Ex. (C) State-3 JH2O2 before and after A/R. (D) The JH2O2:JO2 ratio demonstrates impaired mitochondrial function 
in Sed mitochondria following A/R. (E) A representative experiment showing a trace of resorufin fluorescence used to 
calculate JH2O2 during A/R. For clarity, data were transformed by subtracting the anoxic fluorescent value recorded 
prior to reoxygenation. (F) JH2O2 in isolated mitochondria in the presence of either thioredoxin reductase inhibitor (AF) 
or glutathione reductase inhibitor (BCNU).  Data are shown as mean ± SEM. * p<0.05 vs Sed main effect ; # p<0.05 vs 
Sed baseline. 
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significantly higher than Ex mitochondria following A/R (p<0.05 vs Sed reox, Figure 8D). A 
representative trace for JH2O2 is shown in Figure 8E and demonstrates the lower ROS burst 
during reoxygenation observed in mitochondria from Ex hearts.  
In parallel experiments, the contributions of the thioredoxin and glutathione redox 
systems to ROS scavenging were investigated separately. Mitochondria generated H2O2 was 
measured under state 4 conditions with succinate, incubated with the TrxR inhibitor AF, or the 
GR inhibitor BCNU. Ex and Sed mitochondrial JH2O2 were similar after inhibition with BCNU, 
where as Ex JH2O2 was significantly lower than Sed only after inhibition with AF (p<0.05, Figure 
8F). 
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Discussion 
 The objective of the present study was to determine the effect of exercise-induced 
cardioprotection on mitochondrial bioenergetics and redox homeostasis during reperfusion-
induced arrhythmia. Our findings indicate that exercise decreases arrhythmia through 
mitochondria-dependent mechanisms, including better maintenance of ΔΨm and lower ROS 
production. Several aspects of the present study provide novel insight into mechanisms of 
exercise cardioprotection. First, the simultaneous recording of ΔΨm and ECG in the intact heart 
provides crucial confirmation that mitochondria from exercised hearts have a protective 
phenotype in situ.  We have directly demonstrated that this phenotype correlates with cardiac 
electrical stability.  Second, the continuous, simultaneous recording of mitochondrial O2 
consumption and ROS during in vitro hypoxia/reoxygenation allows us to determine the exact 
time and nature of bioenergetic dysfunction during the metabolic insult itself (as opposed to after 
the injury has occurred). The present study, and our previously published data indicate that the 
maintenance of redox homeostasis through GR is an exercise-induced adaptation that helps 
sustain energetic and electrical coupling in the heart (80, 81). Finally, our vertically integrated 
approach using intact hearts, isolated ventricular myocytes, and isolated mitochondria provides 
comprehensive insight into the endogenous changes that occur in exercised hearts, indicating 
that stabilization of mitochondrial energetics is centrally involved in the anti-arrhythmic effects of 
exercise.  
Maintenance of ΔΨm and lower reperfusion arrhythmia following exercise-induced 
cardioprotection   
 The maintenance of ΔΨm is an important determinant of ischemia-reperfusion injury, cell 
death, and arrhythmia (3, 31, 56, 123). Under conditions of metabolic stress, collapses of ΔΨm 
are known to induce oscillations in cardiac action potential duration due to transient increases in 
sarcolemmal ATP-sensitive K+ channel currents (3, 9, 161, 228). Lability in K+ current during the 
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repolarization phase of the cardiac cycle can alter the spatiotemporal organization of cardiac 
electrical activity and increase the susceptibility to abnormal cardiac rhythms (233).  
In the present study, exercise-induced cardioprotection led to better preservation of ΔΨm in the 
intact heart during early reperfusion with a concomitant decrease in arrhythmia. We also 
observed a more robust preservation of ΔΨm when hearts were pooled for those that 
transitioned to arrhythmia vs. no arrhythmia. Heterogeneous collapses in ΔΨm in intact hearts 
during ischemia/reperfusion have been previously observed using two-photon microscopy (143, 
198) or optical mapping (137). Studies that have looked at ischemia and reperfusion often see 
more robust collapses in ΔΨm at the onset of reoxygenation (143, 198), when ROS levels surge 
and ATP demands resume with the recovery of excitation-contraction coupling (ischemic tissue 
does not contract and thus has lower energy demands). Our findings here are in line with these 
observations as we saw the most robust decline in ΔΨm in cells and hearts at the onset of 
reoxygenation and reperfusion, respectively. While this represents the first direct demonstration 
of preserved ΔΨm in exercised hearts, our results are consistent with previous studies showing 
better maintenance of energetics (reviewed in (79)) and delayed opening of ATP-sensitive 
potassium channels (111) in exercise-conditioned hearts.  
 The overall reduction in oxidant stress with exercise and maintenance of ΔΨm that we 
observed are likely inter-related. In beating hearts, ΔΨm helps to sustain redox homeostasis 
through replenishing endogenous antioxidants via the nicotinamide nucleotide 
transhydrogenase. The cellular redox environment is then regulated by ROS detoxifying 
enzymes (e.g. GR and TrxR) whose activity and subcellular localization controls redox-sensitive 
protein networks. Through second-messenger signaling and post-translational modifications, 
redox chemistry has been implicated in cardiac hypertrophy, remodeling, apoptosis, autophagy, 
and cell death (1, 160, 182). In our study the overall stabilization of energetics contributes to 
improved cardiac function observed after exercise. The redox status of proteins following 
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exercise, such as eNOS (4) and GR (80), appear to play an important role in this protective 
phenotype. Consistent with our findings are other physiological observations following exercise, 
whereby redox modification to the ryanodine receptor enhances SR calcium release (186). 
Furthermore, enhanced redox control may also prevent aberrant SR calcium ATPase activity 
and calcium reuptake by decreasing the oxidation of regulatory thiol-containing residues (173). 
Preservation of cellular GSH and ΔΨm during ischemia/reperfusion with exercise   
 The GSH pool is an essential part of redox homeostasis and an intricate antioxidant 
system used in the scavenging of ROS (188). Recent work implicates the cellular redox state in 
mitochondrial physiology and susceptibility to arrhythmia (8, 31, 81). ΔΨm collapses have been 
observed when GSH levels become oxidized to a critical level, leading to ROS-induced ROS 
release that can scale to depolarize mitochondrial networks (8, 31, 235). Decreasing the cellular 
oxidative burden during an oxidative challenge with perfusion of scavengers or a GSH analog 
prevents the collapse of ΔΨm (87), attenuates shortening of the action potential duration (2), and 
preserves mitochondrial function when isolated from post-ischemic hearts (43).  
 Exercise cardioprotection against arrhythmia has been shown to be dependent on 
enhanced ROS scavenging through several different endogenous mechanisms acting in parallel 
(31, 97, 178). Antisense treatment against MnSOD has been shown to abolish the 
antiarrhythmic effect of exercise (97), corroborating a number of studies that implicate 
heightened MnSOD in exercise-induced cardioprotection (reviewed in (79)). Since the product 
of the dismutase reaction, H2O2, must be further processed to keep overall ROS levels low, 
detoxification by the GSH pool, the largest capacity thiol buffer in heart, is also involved.  Most 
studies find no basal differences in total GSH or the ratio of reduced/oxidized glutathione 
(GSH/GSSG) after exercise, (81, 108, 114, 130) and our work corroborate these findings 
(although there was a trend for myocytes from exercised hearts to have increased basal GSH, it 
did not reach statistical significance).   
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 Although basal GSH/GSSG changes are rarely observed after exercise, the ability to 
replenish the GSH pool during an oxidative insult does appear to be involved. In this study the 
recovery of GSH levels during early reoxygenation correlated with maintained ΔΨm in both heart 
cells and intact hearts. Myocardial GSH levels were also better preserved in hearts as assessed 
with HPLC (Figure 6C). The GSSG content was not significantly different in Ex versus Sed at 
the end of reperfusion, which we also saw in an earlier study (81).  This is likely due to 
heightened cell permeability of GSSG (209), ostensibly diffusing out of the tissue during the 
reoxygenation window. We previously showed that GR activity, which replenishes GSH, was 
enhanced after exercise (80, 81). As pharmacological inhibition of GR during 
ischemia/reperfusion abolished the anti-arrhythmic phenotype of exercise (80), the ability to 
replenish the cellular glutathione pool appears to be centrally involved in exercise 
cardioprotection. Our observation herein that isolated cardiac myocytes exposed to H/R 
displayed enhanced GSH replenishment is also consistent with previous studies in intact 
hearts/cells where Ex protected against injury after perfusion with the thiol-oxidizing agent 
diamide (81).  
Exercise causes intrinsic mitochondrial adaptations that preserve post-ischemic function  
 We used simultaneous acquisition of mitochondrial O2 consumption and H2O2 emission 
during A/R to determine the extent and time-course of endogenous mitochondrial dysfunction. 
Similar studies using electroparamagnetic spin trapping on isolated mitochondria have shown 
that A/R results in a significant rise in superoxide production during the reoxygenation phase 
with concomitant declines in respiratory function (70). Therefore, the A/R insult allows one to 
remove cytosolic and compartmentalized cellular defense systems, unmasking mitochondria-
specific adaptations. 
 Several studies have investigated the effect of A/R on mitochondrial function (70, 71, 
222), but only one following exercise training. Ascensao et al (14). exercised male Wistar rats 
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for 14 weeks at a similar intensity as our protocol, and exposed isolated mitochondria to A/R 24 
hours after the last exercise bout. The exercise group maintained higher post-A/R state 3 
respiratory rates compared to sedentary controls. However, they reported no difference in the 
magnitude of decline in respiration between the two groups (63% and 60% of baseline following 
A/R in Ex and Sed groups respectively). Our study demonstrates that Ex maintains 
mitochondrial energetics following a metabolic insult, assessed by higher percentage of JO2 
recovery following A/R (78% and 68% of baseline for Ex and Sed, respectively). Seeking to 
mimic the in vivo conditions, we used complex I- and II-linked substrates (glutamate, malate, 
pyruvate, and succinate) and physiologically clamped ADP levels (75μM), while Ascensao et al. 
used only complex I substrate and ~400μM ADP, which more closely approaches Vmax and may 
not be as physiologically relevant (53). Recent findings implicate post-ischemic succinate 
accumulation as a driver of mitochondrial ROS production through reverse electron transfer, or 
RET (50) in early reperfusion.  The inclusion of succinate in our mitochondrial buffers may also 
explain the differences observed in this study versus previous work (13).   
 Isolated mitochondria from the Ex group had lower JH2O2 emission following A/R 
compared to Sed, which was especially prominent in early reoxygenation. These findings are 
consistent with observations that exercise lowers cardiac ROS accumulation during 
ischemia/reperfusion (81), protecting against oxidative stress and subsequent collapses in 
mitochondrial bioenergetics. Furthermore, the JH2O2:JO2 ratio was ~2-fold higher in the Sed vs 
Ex group, implying that exercise induces endogenous mitochondrial adaptations that result in a 
lower oxidative burden relative to O2 consumption. 
 Direct demonstration that mitochondria from exercised animals experience lower levels 
of oxidative stress corroborates recent findings. Lee et al. reported that exercise significantly 
decreased the production of H2O2 in actively respiring mitochondria following ischemia-
reperfusion (129). However, Lee et al. isolated mitochondria from the myocardium after the 
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ischemia/reperfusion insult, and one cannot ascertain if better mitochondrial function was a 
cause or a consequence of exercise-induced protection.  
Exercise-induced adaptations enhances GSH replenishment through glutathione reductase  
 We determined if lower ROS bursts following A/R was due to improved scavenging by 
GR and/or TrxR. Inhibition of GR abolished the exercise-induced reduction in ROS, but the 
exercise effect still persisted when TrxR was pharmacologically blocked. These data are in line 
with our previously published data (80, 81) implicating mitochondrial GR in enhanced redox 
control and stabilization of mitochondrial energetics following exercise-induced cardioprotection. 
Although not many studies have examined TrxR in exercise cardioprotection, the lack of 
contribution for this scavenging mechanism we observed is consistent with previous studies 
(62).    
 Measurement of ROS in living systems often represents the net balance between 
mitochondrial production and scavenging.  Improved endogenous scavenging in the heart 
following exercise is clear (5, 79).  It is plausible that Ex mitochondria also produce less ROS.  
Mitochondrial ROS production occurs at several different sites along the Krebs Cycle and 
electron transport system (164).  Mitochondrial Complexes I, III, and supercomplexes can all 
promote formation of reactive intermediates, especially during pathological conditions (142, 
154).  Future studies will continue to advance our understanding of how Ex leads to both 
augmented scavenging, and perhaps lower ROS emission, in cardiac mitochondria.  
 Although exercise studies indicate a role for mitochondrial adaptations in the 
cardioprotective phenotype, there are clear areas that require further investigation. For example, 
the energy-sensing mitochondrial KATP channel has been implicated in exercise 
cardioprotection, and channel blockade abolishes the anti-arrhythmic effect of exercise (178). 
Determining if mitochondrial KATP channel function directly affects ΔΨm and/or cellular redox 
status represents an exciting area for future research. 
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Limitations  
 Although there are several limitations in our study, we tried to address these 
shortcomings with experiments at different levels of tissue organization. First, we used 
blebbistatin for the whole heart imaging experiments to limit motion artifacts. Blebbistatin inhibits 
actin-myosin interactions, but has no effect on calcium cycling and the cardiac action potential, 
which allows for electrical activity to be recorded (69). Still, the clear limitation is that ΔΨm is 
assessed in a model where the energetic demand of contraction is substantially blunted.  For 
this reason, we used field-stimulated cardiac myocytes as an additional measurement of 
mitochondrial function during metabolic insult. Two photon studies are also confounded by the 
limitation that global, no-flow ischemia provides consistent ventricular arrhythmia, but that the 
restoration of coronary flow at reperfusion induces movement artifact as the coronary bed is 
replenished with fluid. This prevents the continuous monitoring of the same section of 
ventricular muscle through ischemia and reperfusion, providing relative signal over time.  We 
also used a mixed population of mitochondria for our experiments, and acknowledge that the 
sub-sarcolemmal and intermyofibrillar mitochondria may have divergent responses to the 
ischemic insult (114, 120, 129). 
Conclusions   
 In summary, our findings demonstrate that exercise helps sustain post-ischemic 
mitochondrial bioenergetics and redox homeostasis, which is associated with preserved ∆Ψm 
and protection against reperfusion arrhythmia. This builds on a growing body of literature that 
indicates a close relationship between the redox environment and stability of ΔΨm. Future work 
aimed at determining the evolution of specific mitochondrial adaptations may assist in 




Chapter 4: Glutathione reductase and redox homeostasis modulates mitochondrial 




Mitochondria are central hubs for the regulation of cellular redox- and energetic-
homeostasis and have been linked to mechanisms of exercise cardioprotection against 
reperfusion arrhythmia (6, 177, 178) and myocardial infarction (129, 170, 201, 227). Glutathione 
reductase is a key enzyme involved in mitigating oxidative stress by maintaining the glutathione 
pool in the reduced state, and our 10-day cardioprotective-exercise model in rats demonstrates 
enhancements in the heart’s capacity to replenish GSH (80, 81). The GSH pool also represents 
a major marker of cellular redox homeostasis and is involved in an intricate antioxidant system 
used in the scavenging of ROS (188). In Chapter 3 I have demonstrated that cell redox status 
plays a critical role in mitochondrial dynamics and susceptibility to reperfusion injury (8, 31, 81). 
Oxidative shifts in the redox environment during I/R leads to opening of inner mitochondrial ion 
channels and mitochondrial permeability transition (9, 10, 52, 235). Subsequent instability in 
mitochondrial membrane potential (ΔΨm) and a collapse in mitochondrial bioenergetics leads to 
ventricular arrhythmia and cell death, both of which are attenuated with exercise (80, 81).  
Modulation of oxidative stress and redox homeostasis through pharmacological and/or 
genetic manipulations has potential for therapeutically treating conditions of I/R (31, 80, 97), 
hypertension (64),  and heart failure (54, 195). Therefore, uncovering mechanisms to restore 
redox homeostasis remains a high priority in the development of treatments of cardiovascular 
disease. Using exercise as a model of cardioprotection we note significant enhancements in 
cardiac glutathione redox regulation, however the extent to which glutathione reductase (GR) 
contributes to preservation of mitochondrial energetics and cardioprotection is unknown. The 
 
   
46 
objective of this study was to utilize pharmacological and genetic modifications of GR to 
determine its impact on cellular bioenergetics under conditions of oxidative stress.
 




The H9c2 rat myocardial cell line was obtained from Sigma and cultured in DMEM with 
10% fetal bovine serum, 1% (v/v) penicillin/streptomycin and 0.25 μg/ml amphotericin B at 37ºC 
with 5% CO2. Cells below passage 20 were used experimentally in this study. To induce 
differentiation and myotube formation, cells were switched to 1% fetal bovine serum and 
supplemented daily with 10nM  all-trans-retinoic acid (Sigma) for 5 days unless otherwise 
stated.  
shRNA plasmid and adenovirus vector production 
Double-stranded 58-mer oligonucleotides encoding shRNAs targeting the glutathione 
reductase gene (Gsr) mRNA (Figure 9) were inserted in place of the 1.9 Kb stuffer region 
between Age I and Eco RI sites of the AddGene pLKO.1 TRC vector (Sigma), under the 
transcriptional control of the human U6 polymerase III promoter. Invitrogen's shRNA generation 
program was used to obtain target sequences for the Gsr shRNA (shgsr). A panel of the target 
sequences screened is shown in Table 1. For screening of shRNAs, H9c2 cells were grown to 
70% confluence and transfected in Opti-MEM with 3μg DNA using the Fugene (Promega) 
transfection reagent at a 3:1 ratio (Fugene/DNA). Cells were incubated in transfection media for 
24hr and then transfected again for another 24hr. Cells were harvested 48hr post transfection 
and GR protein content was determined using Western blots. After identification of positive 
targets, the insert and expression cassette from the pLKO.1 vector was PCR amplified using 
CloneAmp HiFi Premix for cloning into the pAdenoX adenoviral system. The purified PCR 
product was then cloned into a linearized pAdenoX vector using In-Fusion cloning. The In-
Fusion reaction mixture was used to transform Stellar competent E.coli cells, and positive 
colonies were screened using Terra PCR and observed on agarose gel. Positive clones were 
 
   
48 
cultured overnight and purified using the Nucleobond Xtra Plasmid kit. pAdenoX DNA was then 
digested with PacI to expose the inverted terminal repeats (ITRs) for adenoviral DNA 
replication. Adeno-X 293 cells were transfected with CalPhos Mammalian Transfection kit. Upon 
visual cytopathic effects, Adeno-X 293 cells were harvested and exposed to three freeze thaw 
cycles. The supernatant of freeze-thawed cells containing recombinant virus were then 
amplified one time and viral titer was estimated using CloneTech GoStix.  
Glutathione reductase overexpression and adenovirus vector production 
Sprague Dawley rat Gsr mRNA was PCR amplified from cardiac tissue using Tri reagent 
(Sigma). mRNA was converted into cDNA using the Invitrogen Super Script III First Strand 
Synthesis system and polyA enriched RNA was selected for cloning. Gsr primers were used to 
PCR amplify the cDNA using CloneAmp HiFi mix. PCR products were verified by ethidium-
bromide stained on agarose gel and visualized under UV light. The Gsr gene was cloned into 
the pCMV5 shuttle vector using restriction site cloning. Stellar competent cells were transformed 
and selected for positive colonies. The pCMV5 + gsr overexpression cassette was cloned into 
the pAdenoX vector to generate adenovirus (Gsr OE) using the same cloning strategies as 
above. An empty vector expressing GFP was also generated for a vector control (EV-GFP).  
Glutathione reductase shRNA knockdown and overexpression in H9c2 cells 
 H9c2 cells were grown overnight to 70% confluence and then switched to differentiation 
media supplemented with 6μg/mL of polybrene upon adenoviral infection. A multiplicity of 
infection (MOI) of 50 was used to infect H9c2 cells with the shRNA adenoviruses, and a MOI of 
100 was used for the Gsr overexpressing or empty vector adenoviruses. Following 12hr of virus 
exposure cells were switched back to differentiation media and cultured for 4 more days to allow 
changes in gene expression to occur. 
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Hypoxia /reoxygenation in H9c2 cells 
 H9c2 cells were seeded at 10,000 cells per well in 96-well Seahorse plates and 
switched to differentiation media 12 hours later. After 5 days of differentiation, cells were 
exposed to an established model of cellular hypoxia/reoxygenation (12). Cells were subjected to 
0% O2 and deprived of nutrients in Hank’s balanced salt solution (HBSS), and kept in an 
incubator at 5% CO2 for the duration of hypoxia.  
Measurement of respiration in H9c2 cells following hypoxia/reoxygenation  
Following hypoxia cells were returned back to growth media and allowed to recover for 
2hr, or immediately switched to Seahorse XF assay medium and immediately exposed to a 
mitochondrial stress test in a Seahorse XF96 using an injection strategy that included 
oligomycin A (1 μg/ml ), followed by FCCP (4μM), then antimycin A (2μM). Seahorse XF assay 
medium was supplemented with pyruvate (10mM), glucose (10mM), and glutamax (2mM). 
Mitochondrial bioenergetics following pharmacological inhibition of glutathione reductase  
The diothiocarbamate derivative 2-Acetylamino-3-[4-(2-acetylamino-2 
carboxyethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl]propionic acid hydrate (2-
AAPA) was used as a pharmacological model of thiol oxidative stress in H9c2 cells. 2-AAPA 
has previously been used in H9c2 cells to show potent inhibition of Gsr and thioredoxin 
reductase (TrxR) activity, in addition to oxidative shifts in the reduced GSH to oxidized 
glutathione ratio (GSH/GSSG) (226). H9c2 cells were exposed to 2-AAPA for 20min followed by 
bioenergetics analysis. H9c2 cells were seeded at a density of 20,000 cells per well in 96-well 
Seahorse plates 24 hours prior to 2-AAPA exposure. Following a 20 min exposure to 2-AAPA 
cells were washed with Seahorse XF Assay Medium and immediately exposed to a 
mitochondrial stress test in a Seahorse XF96 using the same injection strategy as above. 
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Measurement of mitochondrial membrane potential and cell viability following 2-AAPA exposure 
In parallel experiments mitochondrial membrane potential and cell viability were 
determined in H9c2 cells exposed to 2-AAPA. Cells were seeded at a density of 30,000 
cells/well in a 96-well plate and allowed to attach for 24hr. Cells were then treated in triplicate 
with DMSO, FCCP, or increasing concentrations of 2-AAPA (25μM, 50μM, or 100μM) and 
incubated at 37°C in 5% CO2 for 20 minutes. Mitochondrial membrane potential (∆Ψm) was 
assessed by tetramethylrhodamine, methyl ester (TMRM). TMRM is a membrane-permeant 
cationic fluorescent dye that equilibrates with Nernstian behavior and is sequestered by 
mitochondria. Cells were incubated for 20 minutes in XF Assay medium and 200nM TMRM. . 
Following TMRM loading, cells were washed with Hank’s balanced salt solution and 
fluorescence intensity was measured on a Cytation5 multi-mode microplate reader (BioTek) 
using excitation/emission wavelengths of 540/590nm. In separate experiments, viability was 
determined using PrestoBlue viability reagent (ThermoFisher Scientific) using the manufacturers 
recommended protocol in a Cytation5 multi-mode microplate reader (BioTek).  
Statistics 
 All data are presented as mean ± standard error. Seahorse adenovirus knockdown 
experiments were compared against vector controls using a student’s t-test.  Mean fluorescence 
during reperfusion and respiratory control ratios were analyzed using unpaired Student’s t-test. 
Seahorse 2-AAPA data were analyzed with an ANOVA followed by a Dunnett’s post-hoc test. 
Statistical significance was established when P<0.05. All data were analyzed and graphed using 
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Results 
Gsr knockdown and overexpression adenovirus 
Invitrogen's shRNA generation program was used to obtain candidate target sequences 
for Gsr mRNA transcripts. The target sequences from Table 1 were cloned into the AddGene 





 The optimal concentration of DNA for transfection was empirically determined (3μg), 
with shgsr target #3 as the best candidate for efficient knockdown (Figure 9A and B). The 
pAdeno-X system was used to generate 
four different adenoviruses using the 
expression cassettes depicted in Figure 
9C. The shRNA vectors were under 
control of a human U6 promoter (hU6), 
and the overexpression vectors were 
controlled by a CMV promoter. 
Differentiated H9c2 cells show high 
adenovirus expression 96hr post infection 
(Figure 9D), with time-matched changes 
in Gsr protein expression (Figure 9E).		
Table 1: 58-mer oligonucleotide sequences tested for Gsr knockdown 
shgsr	 Construct	sequence	
#1 5’ CCCAAATTCTAAGGGCCTGAA-CTCGAG-TTCAGGCCCTTAGAATTTGGG 3’ 
#2 5’ GCTCCAAGACGTCTCTTATGA-CTCGAG-TCATAAGAGACGTCTTGGAGC 3’ 
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Figure 9. Gsr knockdown and overexpression in H9c2 
cells. (A) Western blot and densitometry after 48hr 
transfection with shRNA cloned into the pLKO.1 vector. (B) 
GFP and phase images 48hr post transfection. (C) Illustration 
of adenovirus expression cassettes of shgsr, shscram, Gsr 
overexpression (Gsr OE), and empty vector control (EV). (D) 
96hr post infection fluorescent images of differentiated H9c2 
cells, and (E) Western blot of glutathione reductase protein 
content. 
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Modulation of glutathione reductase sensitizes H9c2 cell to mitochondrial dysfunction 
 Mitochondrial 
bioenergetics were studied in 
differentiated H9c2 cells exposed 
to various durations of 
hypoxia/reoxygenation (H/R) 
using glutathione reductase gain- 
and loss-of-function studies. Non-
hypoxic control plates for each 
hypoxic time point were used to 
normalize the data as percent of 
non-hypoxic control (n=16-24 per 
group). Figure 10A and 10B show 
examples of the mitochondrial 
stress test raw data from an 
experiment for the 3hr/0hr H/R 
protocol. There was no difference 
in basal respiration following 3hr or 
18hr hypoxia across groups (Figure 
10C). State 4 leak respiration 
following inhibition of complex V 
with oligomycin was significantly higher in shgsr after 3hr/0hr H/R, but was significantly lower 
after 18hr H/R (p<0.05 vs shscram, Figure 10D). Maximal respiration was significantly lower in 
shgsr after 3hr hypoxia at both 0hr and 2hr reoxygenation, but this was not observed after 18hr 
H/R (p<0.05 vs shscram, Figure 10E). Interestingly Gsr OE had no rescue affect following short 
Figure 10. Mitochondrial bioenergetic analysis in H9c2 cells 
exposed to hypoxia/reoxygenation. (A) Seahorse trace of 
mitochondrial stress test protocol following a 20min 2-AAPA 
exposure. All data were transformed by subtracting out the antimycin 
A respiratory rate. (B) Basal respiration. (C) Maxmial uncoupled 
respiration with FCCP (E) ATP-dependent respiration (Basal 
respiration – State 4). Data in C-E are expressed as percent of Non-
H/R control for each time point. *p<0.05 vs vector control. 
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term 3hr H/R, but at 18hr H/R, maximal respiration and respiratory reserve were significantly 
higher than the EV-GFP control (p<0.05 vs EV-GFP, Figure 10F). In contrast, respiratory 
reserve in shgsr following 3hr H/R was significantly lower, and this effect was lost at 18hr H/R 
(p<0.05 vs shscram, Figure 10F). 
Pharmacological thiol redox stress and mitochondrial function 
To determine the relationship between acute thiol oxidative stress and mitochondrial 
function induced by glutathione reductase inhibition oxygen consumption rate (OCR) was 
measured in H9c2 cells following a 20min dose-response exposure to 2-AAPA (n=8-24 per 
group). OCR was measured using a mitochondrial stress test on the Seahorese XF96 and 
XF96e.  Traces of respiratory rates obtained from the mitochondrial stress test are shown in 
Figure 11A, and were transformed by subtracting the average antimycin A rate for each group. 
Basal respiratory rates were significantly higher than controls at the lower concentrations of 2-
AAPA, and this response was blunted at the higher concentrations (p<0.05 vs CTRL, Figure 
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Figure 11. Mitochondrial bioenergetic analysis in H9c2 cells following pharmacological induction of thiol 
redox stress. (A) Seahorse trace of mitochondrial stress test protocol following a 20min 2-AAPA exposure. All 
data were transformed by subtracting out the antimycin A respiratory rate. (B) Basal respiration. (C) Maximal 
uncoupled respiration with FCCP (E) ATP-dependent respiration (Basal respiration – State 4). (F) Mitochondrial 
membrane ∆Ψm with TMRM and (G) cell viability following 2-AAPA exposures. *p<0.05 vs CTRL (ANOVA followed 
by Dunnett’s post-hoc test). 
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11B). Proton leak under state 4 conditions increases in a dose-dependent fashion up to 75μM 
2-AAPA (p<0.05 vs CTRL, Figure 11C). Maximal respiratory rates increase when exposed to 
lower 2-AAPA concentrations, and this increase is blunted at higher doses (p<0.05 vs CTRL, 
Figure 11D). There was a significant decrease in ATP-dependent respiration at the higher 
concentrations of 2-AAPA exposure, which is opposite compared to the lower concentrations of 
2-AAPA where OCR was significantly higher than control (p<0.05 vs CTRL, Figure 11E). 
Interestingly, the energetic collapse is independent of decreases in ∆Ψm (Figure 11F) and cell 
viability (Figure 11E) with acute 2-AAPA exposures. In fact, cell viability actually increases at 
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Discussion 
The main findings from this study are that glutathione redox potential and thiol redox 
stress play a profound role in mitochondrial dysfunction in acute pathological states. Cellular 
redox homeostasis not only influences ROS scavenging, but also energetic homeostasis and 
cell survival (224). This is supported by a growing appreciation for post-translational redox 
modifications under physiological and pathological conditions (139), and the role of 
mitochondrial function in cardiac physiology. The principle findings from this work are that: 1) 
Gsr deficiency exacerbates mitochondrial dysfunction following a hypoxic insult; 2) Gsr 
overexpression mitigates mitochondrial dysfunction after more severe hypoxic insults; and 3) 
Thiol redox stress modulates mitochondrial function via increasing respiration at lower levels 
and collapsing energetics at higher levels of thiol redox stress.  
Essential to our ability to better treat cardiac I/R injury, is the fundamental role of 
oxidative stress on cellular energetics and mitochondrial dysfunction. In the myocardium 
transient shifts in the redox environment can lead to a perpetual cycle whereby ROS-induced 
ROS release and altered ion homeostasis during I/R increases the susceptibility to a collapse in 
∆Ψm, mitochondrial PTP opening, and cell death (9, 235). Improving our understanding on how 
altered redox homeostasis influences mitochondrial function and myocardial energetics will 
accelerate the development of therapeutics aimed at mitigating damage from ischemic heart 
disease. 
Glutathione reductase and mitochondrial dysfunction following hypoxia/reoxygenation 
Gsr gain- and loss-of-function experiments were employed to determine the impact of 
Gsr on mitochondrial dysfunction following simulation of I/R injury. Cellular GSH levels are 
important mediators of redox homeostasis and have been implicated in several disease models 
including I/R injury (198), insulin resistance (77), and Parkinson’s disease (135). In the present 
study impeding GSH replenishment through an shRNA targeting Gsr was shown to sensitize 
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mitochondria to metabolic insults such as H/R. Following a more sever hypoxic insult 
mitochondria function was partially restored by Gsr overexpression, as demonstrated by 
preserved respiratory capacity and heightened maximal respiration. This demonstrates that 
redox homeostasis is an important pivoting point between maintenance of mitochondrial 
bioenergetics and susceptibility to I/R injury.  
Early work on the role of ROS production in I/R injury implicates the importance of GSH 
in the cardioprotective phenotype, as GSH supplementation prevented myocardial dysfunction 
following short periods of ischemia in isolated Langendorff perfused hearts (22). Furthermore, 
cardiac GSH depletion exacerbates myocardial infarction and recovery of contractile function, 
while intravenous GSH infusion reverses these defects (196). These findings support the results 
herein by demonstrating that enhanced redox control leads to preservation of mitochondrial 
function and that the recovery of post-ischemic cardiac dysfunction is intimately related to the 
maintenance of GSH/GSSG redox potential (140). 
Pharmacological thiol redox stress leads to decompensated mitochondrial function 
In the present study the use of a dithiocarbamate derivative, 2-AAPA, was used to 
induce thiol redox stress in H9c2 cells to better understand the acute consequences of altered 
redox homeostasis on mitochondrial function. Upon low levels of acute thiol redox stress, basal 
and maximal respiratory rates increase above that of control levels. However, after more severe 
redox stress, respiratory function declines and mitochondria become uncoupled as shown by 
elevated leak respiration and significant reductions in ATP-dependent respiration. Interestingly, 
the energetic collapse was independent of detectable changes in ∆Ψm and viability, indicating 
that redox stress and subsequent mitochondrial dysfunction play a larger role upstream in the 
development of I/R injury. 
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2-AAPA is a potent inhibitor of GR and has been shown to be more specific than other 
GR inhibitors with an IC50 of 50µM (192). A 20min exposure to 2-AAPA in H9c2 cells leads to a 
significant reduction in GSH/GSSG, ranging from ≈40% reduction with 25µM 2-AAPA to ≈80% 
reduction with 100µM 2-AAPA (226).  The dose and exposure times of 2-AAPA used in their 
studies are consistent with the present study and demonstrate that mitochondria are extremely 
sensitive to acute alterations of the redox environment and that mitochondrial respiration is 
highly responsive to the thiol redox status of the cell.  
Directly altering the thiol redox status of the cell through the GSH/GSSG ratio allows one 
to isolate the response of oxidative phosphorylation machinery to redox stress. Although the 
mechanisms and physiological significance of altered protein thiol modifications are uncertain 
and remain an area of active investigation. The role of ROS in the damage associated with I/R 
injury has been well established. And while much of the early work focused on the antioxidant 
properties of GSH as a function of the redox environment, it has now become clear that redox 
reactions through GSH go far beyond the scavenging of ROS. But less clear are the consequent 
changes to the redox environment (i.e. GSH/GSSG) and alterations to protein thiol redox states.  
Mitochondrial proteins contain many cysteine thiols that act as redox switches involved 
in mitochondrial bioenergetics. Reactive protein thiol groups can undergo a number of redox 
modifications to either enhance or suppress enzymatic activity, including direct oxidation, thiol-
disulfide exchange with GSSG, and sulfenic acid intermediates among others (91). Redox-
glutathionylation modifications to complex I (46) and II (47) have been found to play protective 
roles in the post-ischemic myocardium by limiting ROS production and preserving enzymatic 
activity. The reversible formation of protein mixed disulfide via glutathionylation may serve to 
protect electron transfer in response to oxidative stress (45). In the present study, the increase 
in maximal mitochondrial respiration with lower concentrations of 2-AAPA (Figure 11) is 
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attributed to increased glutathionylation of Complex I, as 2-AAPA has been found to increase 
glutathionylation of proteins in a dose-dependent manner (226). Furthermore, in vitro studies 
using a different GR inhibitor, BCNU, have reported similar increases in mitochondrial 
respiratory capacity, which coincided with increased Complex I glutathionylation.  
Limitations  
 One of the limitations of this study is the absence of an energetic demand from 
excitation-contraction coupling, which when inhibited in the myocardium, alters the susceptibility 
to I/R injury (6). Important to this study is the role of oxidative stress on mitochondrial 
bioenergetics, however one cannot rule out the effect of calcium on alterations in mitochondrial 
respiration during oxidative stress. This is especially noted because in primary cardiomyocytes 
calcium homeostasis plays a significant role in cardiac I/R pathologies (236). Furthermore, 
several groups have established that calcium kinetics are intricately linked with mitochondrial 
bioenergetics and oxidative stress through regulatory thiol groups on the ryanodine receptor 
being susceptible to oxidation and increasing open probability of the channel (68, 173, 232).  
Conclusions  
In conclusion this study demonstrates that endogenous redox regulatory mechanisms 
can be targeted to influence the sensitivity of mitochondria to hypoxic insults. This provides 
insight into how an altered redox environment may affect mitochondrial function during the first 
few minutes of reperfusion when the production of ROS and cellular oxidative stress leads to 
myocardial injury. These studies implicate the targeting of GR as a potential therapeutic target 




Chapter 5: The effects of NADPH-oxidase generated ROS during exercise on post-




 Cardiovascular disease remains one of the leading causes of death in North America, 
and although rates of death attributable to cardiovascular disease have declined in recent years, 
the burden of disease remains high (94). It has been estimated that 1,000,000 Americans suffer 
acute coronary syndromes annually (152), which increases ones risk for myocardial infarction 
and fatal ventricular arrhythmia in particular. The cardioprotective effect of exercise on 
decreasing severity of myocardial infarction and arrhythmia has been well documented (27, 32, 
80, 132, 176, 177, 207), however, cellular mechanisms are not fully understood. Exercise-
induced cardioprotection is most likely a result of increased cardiac antioxidant capacity (80, 81, 
97), decreased sensitivity to apoptotic stimuli (120, 176), and conservation of mitochondrial 
function (28, 125, 129). Recent clinical trials investigating mitochondrial-targeted therapeutics 
demonstrate that mitochondrial-medicine remains a high priority as a viable treatment for 
ischemia/reperfusion (I/R) injury (57, 92, 145, 169). Accordingly, identifying the underlying 
mechanisms responsible for exercise cardioprotection merits further investigation, as it may 
foster new treatments that evoke sustainable cardiac protection against acute coronary 
syndromes.  
 We previously demonstrated that NADPH-oxidase (NOX) generated ROS play a critical 
role in exercise cardioprotection (80). Activation of NOX-generated ROS during exercise was 
essential for the hormetic response, leading to an increase in glutathione reductase (GR) 
activity, and decreasing myocardial infarction following I/R. GR is an important component to the 
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oxidative stress defense system by maintaining the GSH pool and preserving redox 
homeostasis (6). Furthermore, oxidative stress from mitochondrial derived reactive oxygen 
species (ROS) have been linked to post-ischemic cardiac dysfunction and cell death (26, 80, 
214, 235). An overwhelming oxidative stress has a negative effect on mitochondrial energetics, 
and can also damage mitochondrial inner-membrane lipids. Mitochondrial membranes are rich 
in phospholipids and are susceptible to oxidative modifications that can alter the biophysical 
properties of the membrane, which can have a profound effect on protein activity and ultimately 
mitochondrial function (48, 194, 230). To date, studies have characterized how exercise 
attenuates defects of the mitochondrial electron transport system after ischemia/reperfusion (29, 
129), yet few studies have examined this in the context of altered redox homeostasis and 
subsequent changes to the mitochondrial membrane lipid environment. The objective of this 
study was to test the hypothesis that exercise cardioprotection through NOX-generated ROS 
leads to preserved fluidity of the inner mitochondrial membrane, enhanced supercomplex 
assembly, and better post-ischemic mitochondrial function.   
 




Male Sprague Dawley rats (300-350g) were housed on a 12/12 hour light/dark cycle with 
food and water provided ad libitum.  Experiments were conducted in accordance with NIH 
guidelines and approved by East Carolina University’s Animal Care and Use Committee 
(Internal Animal Use Protocol #Q279a and #Q279b). Rats were anesthetized by injecting 
ketamine/xylazine i.p. (90mg/kg ketamine, 10mg/kg xylazine). Following absence of toe reflex, 
hearts were excised via midline thoracotomy, placed briefly in 0.9% saline (4ºC) and used for 
isolated heart studies. 
Exercise protocol and drug treatment  
Rats were injected 30 minutes prior to each exercise bout with the NADPH-oxidase 
inhibitor VAS2870 (2mg/kg) or DMSO as a vehicle control (Exercise+DMSO or Exercise+VAS). 
Rats were acclimated to the treadmill over three days, running at a speed of 15 m/min, and 
increasing the duration to 5, 10, and 15 min each day. Rats in the exercise group underwent 10 
days of consecutive treadmill running at 6% grade for 60 min per day, in intervals broken up to 
15 m/min for 15 min, 30 m/min for 30 min, and 15 m/min for 15 min. Sedentary rats were 
injected with DMSO or VAS2870 and placed on a non-moving treadmill for 5 min each day 
(Sedentary+DMSO or Sedentary+VAS). All hearts were used experimentally 24 hours after 
completion of the 10-day protocol or after the time-matched sedentary control. 
Whole heart Langendorff experiments 
Isolated hearts (n=4/group) were perfused in Langendorff mode with gassed (95%O2, 
5%CO2) Krebs Henseleit buffer at 37ºC containing (mM): 118 NaCl, 24 NaHCO3, 4.8 KCl, 2 
CaCl2, 1.2 MgSO4, 1.2 KH2PO4, and 10 glucose (37ºC). A Transonic flow probe was used to 
monitor coronary flow during the protocol. Cardiac function parameters including heart rate 
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(HR), left-ventricular developed pressure (LVDP), and the rate of pressure development over 
time (+/- dP/dT) were monitored and recorded. A latex balloon was inserted into the left ventricle 
for isovolumic LVDP recordings. Electrocardiogram (ECG) recordings were obtained via 
volume-conductance using electrodes placed in a water-jacketed bath maintained at 37ºC. All 
parameters were recorded and analyzed using Lab Chart 7.0 software (A.D. Instruments). After 
a 10 min baseline and stabilization period, hearts were exposed to 20 min of global no-flow 
ischemia, followed by 2 hours or reperfusion. Myocardial infarct size and arrhythmia was 
assessed following reperfusion as previously described (80). 
Mitochondria isolation 
A subset of hearts were exposed to I/R and cardiac mitochondria were immediately 
isolated following the protocol to assess mitochondrial function. Following the protocol the left 
ventricle was dissected and minced on ice in mitochondrial isolation medium (MIM) + BSA 
containing (in mM): 300 sucrose, 10 sodium-HEPES, 1 EGTA, and 1mg/ml BSA. The minced 
heart was then homogenized followed by centrifugation at 800xg for 10 min. The supernatant 
was centrifuged at 12,000xg for 10 min to pellet mitochondria. The pellet was then resuspended 
in MIM and kept on ice until experimentation. 
Mitochondrial O2 consumption rate and H2O2 emission rate  
Mitochondrial function (n=4/group, run in duplicate) was measured polargraphically and 
fluorometrically using the Oroboros high-resolution respirometry oxygraph-2k (o2k) with the 
fluorescent module. Mitochondria were injected into the o2k in Buffer Z + Amplex UltraRed 
assay medium containing (in mM): 110 K-Mes, 35 KCl, 1 EGTA, 5 K2HPO2 , 3 MgCl2-6H2O, 
0.5 mg/ml  BSA, and 25 creatine monohydrate. The rate of H2O2 emission was quantified using 
Amplex UltraRed (25μM), horseradish peroxidase (4U/mL), and superoxide dismutase (SOD, 
30U/mL). First mitochondria were energized with glutamate (10mM), malate (2mM), and 
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pyruvate (5mM) to assess complex I-dependent respiration with maximal adenosine 
diphosphate (ADP) stimulation (4mM). Succinate (10mM) was then injected to assess complex I 
+ II respiration. Complex II-dependent respiration was measured by the addition of rotenone 
(1μM), which blocks complex I activity. To ensure equal amounts of mitochondrial protein 
loading across experiments, citrate synthase activity was measured by following TNB 
spectrophotometrically using previously published methods (127).  
Mitochondrial enzyme kinetics 
 Frozen mitochondria from I/R hearts were utilized for mitochondrial enzyme kinetic 
analysis using previously published methods with slight modifications (194). Activities were 
determined spectrophotemetrically in triplicate at 37°C in 1mL total reaction volume. Citrate 
synthase activity was determined in frozen mitochondria (10μg total protein) in hypotonic 
medium containing: 10mM Tris (pH 7.5), 0.31mM acetyl-CoA, 0.1mM 5,5’-dithiobis-(2-
nitrobenzoic acid) (DTNB), and 0.25% Triton X-100. The reaction was initiated with the addition 
of freshly prepared oxaloacetate (0.5mM), and the reduction of DTNB was monitored at 412nm 
for 3 min. Citrate synthase activity (n=4/group; run in triplicate) was calculated using an ε412 
14140 M-1cm-1. Averages of citrate synthase specific activities were used to normalize the 
specific activity of Complex I. 
 Complex I (NADH: decylubiquinone oxidoreductase) specific activity (n=4/group; run in 
triplicate)  was determined in frozen mitochondria that underwent two 30-sec freeze thaw cycles 
in hypotonic medium. Mitochondria (40μg total protein) were added to a working reagent 
containing: 50mM Tris (pH 8.0), 5mg/mL BSA, 240μM potassium cyanide (KCN), 4μM 
Antimycin A, and 100μM decylubiquinone, and the reaction was initiated with the addition of 
0.08mM NADH. The oxidation of NADH to NAD+ was followed at 340nm for 3 min and an ε340 of 
6220 M-1cm-1 was used to calculate activity of complex I. Separate experiments were carried out 
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in the presence of rotenone (4μM) to ensure that the rotenone-sensitive catalytic oxidation of 
NADH was being measured. 
Mitochondrial membrane phospholipid packing following ischemia/reperfusion 
Mitochondrial membrane lipid packing was assessed in mitochondria (n=4/group; run in 
duplicate) from post-ischemic hearts using Merocyanine 540 (MC540). Fluorescence spectra 
were recorded using a Jobin Yvon Fluorolog spectrofluorometer at 37ºC. Excitation was set at 
495nm, and emission spectra were obtained from 540-660nm using 5nm steps. MC540 
fluorescence measures the degree of phospholipid packing in model and biological membranes 
(126), with increasing fluorescence upon the gel to liquid phase transition. Isolated mitochondria 
(0.2mg/ml) were added to MIM + MC540 (75nM) and incubated for 10 minutes. Spectra 
recordings were made prior to the addition of mitochondria and were subtracted from the 
spectra after the addition of mitochondria. 
Respiratory supercomplex analysis following ischemia/reperfusion 
Mitochondria from post-ischemic hearts (n=4/group; run in duplicate) were isolated and 
supercomplexes were measured via Blue Native-Polyacrylamide Gel Electrophoresis (BN-
PAGE) using published protocols with slight modifications (189). Mitochondria were solubilized 
(4°C for 15min, digitonin:protein ratio of 8:1), and the lysate centrifuged for 30min at 16873 x g 
(4°C). Protein quantification (BCA assay) was performed on the supernatant, after which 36μg 
was loaded into a 3-12% gradient gel. Samples were run at 150V for 3 hours, after which the 
gels were fixed and then washed overnight at 4°C to remove background staining. 
Supercomplexes were quantified using densitometry using NIH image J software. 
Statistics 
 All data are presented as mean ± standard error. All data were compared to vehicle 
controls using a student’s t-test. Statistical significance was established when P<0.05. All data 
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were analyzed and graphed using GraphPad Prism software. 
 
   
66 
Results 
Exercise reduces ischemia/reperfusion injury through an NADPH-oxidase dependent 
mechanism 
 Hearts from rats (n=5 to 7 per group) in the Exercise+DMSO (ED) group experienced a 
reduced infarct size by 31% compared to Sedentary+DMSO (SD) (P<0.05, Figure 12A). The 
administration of VAS2870 prior to each exercise bout (EV) blunted exercise-induced 
cardioprotection against myocardial infarction and arrhythmia (Figure 12A and 12B). The anti-
arrhythmic effect of exercise was evident during early reperfusion (first 15 minutes) as shown by 
the significant reduction in arrhythmia score (ED, 1.6±0.4 vs SD, 3.1±0.6; P<0.05, Figure 12B), 
while exercised animals administered VAS2870 demonstrated only a modest non-significant 
reduction in arrhythmia compared to controls (EV, 2.3±0.6 vs SV, 3.0±0.4; P>0.05, Figure 12B). 
The time to ischemic contracture was also blunted in ED animals compared to SD (P<0.05, 








































































Figure 12. Infarct size and arrhythmia in isolated hearts following ischemia/reperfusion. (A) Infarct size for 
isolated rat hearts following 20 minutes of ischemia and 2 hours of reperfusion. (B) Arrhythmia score following the 
first 15 minutes of reperfusion. (C) The time to contracture was determined by calculating the amount of time 
elapsed during ischemia leading to a 5mmHg increase in end-diastolic pressure (EDP). All data are mean ± SEM, 
n=5-7 per group. * P<0.05 vs SD. 
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Post-ischemia/reperfusion mitochondrial O2 consumption rate and H2O2 emission rate  
 Following I/R, a subset of hearts was used experimentally to isolate and study 
mitochondrial function (Figure 13). Rates of O2 consumption (JO2) and H2O2 emission (JH2O2) 
were measured simultaneously using the Oroboros high-resolution respirometry oxygraph-2k. 
There was no difference in JO2 under state 4, non-phosphorylating conditions with glutamate, 
malate, and pyruvate (GMP) (Figure 13A). JO2 with complex I substrate under saturating ADP 
conditions was lower in exercised rats compared to sedentary controls, however statistical 
significance was only reached in the EV group (P<0.05 vs SV, Figure 13B). Citrate synthase 
activity in isolated mitochondria was determined by monitoring the reduction of DTNB following 

































































































































































Figure 13. Mitochondrial function following ischemia/reperfusion injury. (A) O2 consumption rate (JO2) in 
isolated mitochondria under state 4 conditions (no ADP) with glutamate (10mM), malate (2mM), and pyruvate 
(5mM). (B) JO2 under state 3 conditions with saturating ADP (4mM). (C) Citrate synthase activity. (D) Relative 
specific activity of complex I normalized to the respective citrate synthase activity. (E) H2O2 emission rate (JH2O2) 
under state 4 conditions (same substrate as Figure 2A). (F) JH2O2 with saturating ADP. All data are mean ± SEM, 
n=4 per group, JO2 and JH2O2 assays were run in duplicate and kinetic assays were run in triplicate. * P<0.05 vs 
SD, # P<0.05 vs SV. 
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Relative specific activity of complex I was determined by following NADH oxidation to NAD+ 
after addition of the electron accepter, decylubiquinone. Complex I activity was significantly 
higher in ED vs SD and VAS2870 administration prior to exercise reversed this (P<0.05 vs SD, 
Figure 13D). JH2O2 was lower in ED vs SD under state 4 conditions, and this differences was 
lost with VAS2870 administration prior to exercise (P<0.05 vs SD, Figure 13E). Similarly, JH2O2 
was significantly lower only in ED vs SD under state-3 respiration (P<0.05 vs SD, Figure 13F). 
Exercise cardioprotection is independent of altered post-ischemic inner mitochondrial 
membrane lipid packing and supercomplex assembly  
Mitochondria were isolated following I/R and used in parallel experiments to study the 
biophysical properties of the inner mitochondrial membrane using MC540 and respiratory 
supercomplex assembly via BN-PAGE (Figure 14). Lipid packing of the mitochondrial 
membrane was observed by recording MC540 fluorescence spectra following 10 minutes of 
incubation at 37ºC. There was no difference in the MC540 spectra between groups (Figure 14A 
and 14B). Similarly, there was no difference in peak fluorescence between groups indicating a 
similar degree of lipid packing following I/R (Figure 14C). Mitochondrial supercomplex assembly 
(complexes I, III2, and IV) was determined using BN-PAGE and was not different between 
groups (Figure 14C and 14D)  
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Figure 14. Mitochondrial membrane lipid properties and respiratory supercomplex assembly. (A) 
Merocyanine 540 (MC540) fluorescent spectra before and after the addition of mitochondria. Note the peak 
fluorescence red shift of the spectra indicates a lipid phase (B) Relative shift in MC540 fluorescence following the 
addition of mitochondria (F-F0). C) Peak fluorescence intensity at 600nm. D) Representative image of 
supercomplex density via Blue-native PAGE; n=4 per group run in duplicate. The black box encloses 
supercomplex I, III2, IV and used for quantification. E) Quantification of densitometry from supercomplex gel, 
normalized to control. All data are mean ± SEM, n=4 per group. 
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Discussion 
 The objective of the present study was to determine the role of NOX in exercise 
cardioprotection and the resultant phenotype of post-ischemic mitochondria. The main findings 
are: 1) Exercise cardioprotection against myocardial infarction and arrhythmia are abolished 
when cardiac NOX enzymes are inhibited during exercise with VAS2870, 2) post-ischemic 
mitochondrial complex I activity was higher, and H2O2 production was lower in isolated 
mitochondria from exercised hearts, and 3) exercise-induced cardioprotection occurs through a 
mechanism that is independent of changes in mitochondrial membrane lipid packing and 
respiratory supercomplex assembly.  
 Based on our previous work, the heart’s adaptive response to exercise appears to be 
closely linked with improved maintenance of cellular redox homeostasis and preservation of 
mitochondrial membrane potential (ΔΨm) during ischemia/reperfusion injury (6, 80). These 
studies suggested that a stimulus ROS produced during exercise, and acute alterations to the 
redox environment, leads to an adaptive/protective phenotype with exercise training. However, 
the localization and compartmentalization of cellular redox biology increases the complexity of 
exercise-generated ROS in cardioprotective signaling. In an earlier study we injected rats with 
apocynin, a NOX-2 inhibitor, prior to exercise to demonstrate that NOX-generated ROS during 
exercise leads to protection against myocardial infarction. This adaptation was associated with 
the transient bouts of thiol stress experienced during exercise (80). However, apocynin has 
been questioned for its specificity and has been shown to act as a ROS scavenger in vascular 
systems (101). Also, several studies have demonstrated that VAS2870 is superior for its 
specificity of NOX inhibition (101, 181), and thus was chosen herein to further characterize the 
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Inhibition of NADPH-oxidase during exercise abolishes exercise cardioprotection 
 Administration of VAS2870 abolished the protective effect of exercise as measured by 
myocardial infarct size, arrhythmia, and time to contracture (Figure 12). The reduction in infarct 
size corroborates the loss of exercise-induced protection that we previously reported in 
exercised rats administered the NOX inhibitors (apocynin or VAS2870) prior to exercise (80), 
and builds on this by demonstrating that inhibition of NOX prevents the anti-arrhythmic 
phenotype observed with exercise. An increase in time to contracture during ischemia has 
previously been used as an indicator of preserved ATP homeostasis (113), and is consistent 
with the idea that exercise preserves cellular ATP and delays the onset of diastolic contracture . 
Furthermore, these findings support the hypothesis that mitochondria play a role in the 
protective phenotype, and that targeting mitochondrial function can influence the severity of 
pathology.  
Isolated mitochondrial function from the post-ischemic heart 
 Mitochondrial function and ROS production has been shown to be a major determinant 
of cardiac ischemia/reperfusion injury (7, 26). Given the importance of ROS signaling in 
mediating mitochondrial adaptations in various cardioprotective paradigms we determined how 
inhibiting NOX-generated ROS affected post-ischemic mitochondrial function. Contrary to our 
hypothesis, an interesting finding from the study was that isolated mitochondria from exercised 
hearts exposed to I/R had lower mitochondrial respiratory rates under state-3 conditions when 
respiring on complex-I substrate (Figure 13B). Although not statistically significant in the ED vs 
SD groups, there was a trend for lower respiration, and this was statistically significant in the EV 
vs SV groups. This is not the first time we have observed similar complex-I linked respiratory 
rates in isolated mitochondria from post-ischemic hearts of sedentary and exercised rats (Rick 
Alleman unpublished data). These findings contrast those of Lee et al. who observed 
significantly higher complex-I dependent respiration from isolated mitochondria of exercised 
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rats. However they used a 40 min ischemia and 45 min reperfusion protocol in a Langendorff 
working-heart model (129), which may explain the discrepant findings. Our findings demonstrate 
that cardioprotection can be achieved in the absence of higher mitochondrial respiratory rates 
by complex I. However, this is not unprecedented, as other studies have noted little to no 
difference in complex-I linked mitochondrial respiration with remote ischemic preconditioning 
(RIP), another well-established cardioprotective model (75).  
After observing lower complex-I linked respiratory rates in mitochondria from exercised 
rats we wanted to determine the activity of citrate synthase, as this has been used as a 
quantitative marker of intact mitochondria (102, 127). The activity of citrate synthase was not 
different across groups, confirming the loading of equal mitochondria in respiratory experiments. 
An interesting finding however, was that complex I activity was significantly higher only in the 
ED group (Figure 13D). While it is difficult to explain the discrepancy in complex I respiration vs 
complex I activity, one hypothesis is that mitochondria from exercised rats are more efficient 
and/or have lower demand by other energy consuming pathways such as the nicotinamide 
nucleotide transhydrogenase (NNT). Merit to this hypothesis comes from studies demonstrating 
that NNT can act as an “energy-consuming redox circuit” due to NADPH oxidation in redox 
reactions and subsequent reduction through NNT utilization of ΔΨm (136). In addition, several 
redox-sensitive sites on complex I have been shown to decrease enzyme activity under 
heightened redox stress (106). Therefore, it is plausible that heightened complex I activity in the 
ED group is a marker for mitochondrial reserve capacity to scavenge ROS and metabolic 
demand matching of the cell. This hypothesis is in line with our data showing lower post-
ischemic mitochondrial H2O2 emission in the ED group following I/R, and VAS2870 
administration abolished the lower H2O2 emission observed with exercise alone (Figure 13E and 
13F). Furthermore, the lower H2O2 emission observed in ED mirrored the reduction in infarction 
and protection against arrhythmia, both of which were abolished with VAS2870. Next, we 
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sought to determine if the lower H2O2 emission rates and heightened enzyme activity with 
exercise were due to a more fluid inner-mitochondrial membrane, and preserved assembly of 
supercomplexes. Both of which have been implicated in the cardioprotective mechanism of the 
mitochondrial targeting peptide, SS-31 (Unpublished data).  
Post-ischemic mitochondrial membrane lipid packing and supercomplex assembly following 
exercise cardioprotection 
 Following I/R injury, no differences in lipid packing in cardiac mitochondria were 
observed between groups using MC540 (Figure 14C). We hypothesized that lower H2O2 
production and preserved complex I activity in isolated mitochondria from exercised rats was 
due to a more fluid mitochondrial membrane and preserved respiratory supercomplex assembly. 
However, we also did not detect any differences in supercomplex assembly across groups 
(Figure 14D and 14E). A decrease in lipid packing was expected in the ED group, as this would 
indicate preservation of membrane polyunsaturated acyl chains and perhaps more abundant 
cardiolipin content. The structure, assembly, and composition of mitochondrial membrane 
phospholipids plays a significant role in mitochondrial bioenergetics under normal and 
pathological states (51). Altering the lipid composition of membranes can affect its biophysical 
properties, including membrane microviscosity as well as lateral diffusion and protein 
interaction.  
The inner-mitochondrial membrane is mostly composed of three different phospholipids: 
phosphatidylcholine, phosphatidylethanolamine, and cardiolipin (165). Of these phospholipids, 
cardiolipin imparts a unique characteristic to the lipid environment due to its bicyclic structure 
and acyl chain orientation (133). Furthermore, cardiolipin has been shown to be important for 
respiratory supercomplex assembly (168) and optimal mitochondrial respiratory function (20). 
During I/R injury total cardiolipin content appears to decrease, which mirrors decrements in 
complex I activity and increased H2O2 production (167). Paradies et al. 2004 found that fusion of 
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exogenous cardiolipin with mitochondria from post-I/R hearts restored complex I activity to 
control non-ischemic levels (167). These previous studies demonstrate the importance of 
cardiolipin in mitochondrial function, yet it is unknown how exercise affects cardiolipin content in 
the post-ischemic heart. 
Preserved mitochondrial membrane fluidity following I/R has been demonstrated using 
steady state fluorescence anisotropy of DPH in a cardioprotective remote ischemic 
preconditioning model (75). However as mentioned previously, this study also found no 
difference between RIP and I/R alone on state 3 mitochondrial respiration. In a more recent 
study by the same group, RIP once again preserved mitochondrial membrane fluidity following 
I/R using DPH (76). These studies support the idea of targeting the inner-membrane in acute 
coronary syndromes. 
Limitations 
In the present study non-I/R controls were not utilized for comparisons, however we 
have previously observed decrements in mitochondrial membrane fluidity, supercomplex 
breakdown, and perturbations in post-ischemic mitochondrial function (unpublished data). The 
MC540 probe was used this study because it has been extensively characterized in model 
membrane systems where it localizes to membranes and orients perpendicular to phospholipid 
chains (223, 230). However, one limitation of this technique is its localization to the membranes 
outer leaflet, and superficial positioning in relation to the inner membrane, where more 
exaggerated changes may occur. In addition, the interpretation of membrane properties must be 
done cautiously as changes in lipid packing with cardiolipin can induce divergent MC540 
fluorescent spectra in the presence of different mixtures of lipid species (230). While we did not 
detect any differences across groups using MC540, complimentary measurements of 
fluorescence anisotropy using diphenylhexatriene (DPH) and/or fluorescence resonance energy 
transfer (FRET) probes would help determine the extent to which exercise-induced 
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cardioprotection involves alterations in biophysical properties of the inner-mitochondrial 
membrane.  
Conclusions  
It is widely accepted that exercise helps sustain mitochondrial function and cellular ATP 
levels during I/R (28, 129, 178). In the present study exercise cardioprotection resulted in higher 
complex I activity and lower H2O2 production in isolated mitochondria from post I/R hearts and 
this cardioprotective phenotype is lost with VAS2870 administration. While it seemed plausible 
that supercomplex assembly would be preserved in exercise as well, we did not observe any 
differences in respiratory supercomplex assembly across groups following I/R. Although this is 
not surprising based on the analysis of the mitochondrial lipid environment. Given this, it seems 
more likely that exercise-induced cardioprotection is a result of preserved biochemical 
mitochondrial adaptations, rather than biophysical alterations. However more research is 
needed to definitively determine if lipid microdomains are influenced by exercise, and to what 
extent these changes have on the cardioprotective phenotype.
 
 
Chapter 6: Integrated discussion 
Major Findings 
The central hypothesis of this work is that exercise-induced cardioprotection is a result of 
stabilization of mitochondrial bioenergetics and preservation of cellular thiol redox status. The 
findings from this work establish that the interdependence of cellular redox control and 
mitochondrial function is an important mediator of exercise-induced cardioprotection. 
Furthermore, modulation of glutathione reductase has a profound effect on cellular response to 
metabolic insult, and targeting this system is an attractive therapeutic target. Together these 
studies provide unprecedented insight into the metabolic abnormalities mitigated through 
exercise cardioprotection.   
The work in this dissertation indicates that oxidative stress during I/R injury leads to 
mitochondrial dysfunction and a collapse in cellular energetics. In Chapter 3 it was shown that 
exercise prevents the collapse in energetics by decreasing the oxidative burden on the cell. 
Maintenance of GSH and lower production of ROS during early reperfusion was shown to be 
critical in stabilizing energetics and mediating the antiarrhythmic effect of exercise (Figure 3). 
The maintenance of GSH through enhanced redox buffering was linked to GR activity as it has 
previously been demonstrated that exercise increases cellular GR activity (80). In Chapter 4 the 
importance of GR on mitochondrial function was assessed through pharmacological inhibition or 
through adenovirus mediated alterations in Gsr expression. These studies provide 
unprecedented insight into the role of redox regulation on mitochondrial function during 
pathological oxidative stress conditions. Finally, in Chapter 5 we determined how inhibiting the 
cardioprotective ROS stimulus during exercise impacted post-ischemic mitochondria. We 
demonstrate that inhibition of NADPH oxidase (NOX) abolished exercise cardioprotection 
(Figure 12). However, the protective phenotype was not a result of alterations to the 
mitochondrial lipid environment, or preservation of supercomplex assembly. Rather, limiting the 
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production of ROS and maintenance of redox homeostasis through exercise-induced 
adaptations appeared to be more responsible for the protection against arrhythmia and infarct 
sparing observed with exercise.   
The finding that exercise-induced cardioprotection does not operate through stabilization 
of mitochondrial supercomplexes (Figure 14) demonstrates divergent strategies for the 
protection of myocardium during I/R injury, as recent studies with mitochondrial targeting 
peptides have been hypothesized to protect the myocardium by stabilizing supercomplex 
assembly and preserving mitochondrial energetics (unpublished data). The discovery of 
potential therapeutics for the treatment of acute coronary syndromes is important with very few 
drugs reaching primary endpoints in clinical trials, and even fewer translating into clinical 
practice (100). Therefore, furthering our understanding on how redox biology regulates 
mitochondrial function is a critical step in advancing our knowledge on the treatment of I/R 
injury. 
Future Directions 
The studies presented herein demonstrate how the redox environment alters 
mitochondrial function, and that enhanced redox control may be a key underlying factor in the 
cardioprotective effect of exercise. In Chapter 3 it was demonstrated that maintenance of GSH 
was strongly associated with the stabilization of energetics and protection against arrhythmia, 
however it would be interesting to determine the extent to which exogenous GSH administration 
affects the observed collapse in ∆Ψm during reperfusion.  
To address the role of the redox environment on mitochondrial energetics, in Chapter 4 
we engineered adenovirus constructs aimed at altering Gsr expression in order to better 
understand the consequences of oxidative stress on the cardioprotective phenotype. Our 
preliminary studies demonstrate promising results in regard to modulating endogenous redox 
control mechanisms for the treatment of I/R injury. While these studies were conducted in vitro, 
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it is critical to better understand how manipulation of redox control through this approach 
translates to in vivo cardioprotection. Given the importance of the redox environment and GSH 
homeostasis on modulating cellular energetics, it will be interesting to determine if modulation of 
Gsr expression in animals exposed to exercise training are still able to maintain the 
cardioprotective phenotype observed under normal conditions.  
Chapter 5 investigated how inhibiting NOX during exercise affected post-ischemic 
mitochondria, as we have previously observed a loss of exercise-induced cardioprotection with 
the NOX inhibitors apocynin and VAS2870 (80). This earlier study characterized how apocynin 
prevented the upregulation in GR activity observed with exercise, and did not fully characterize 
the affect of VAS2870 on GR activity. While VAS2870 has been shown to be a more specific 
inhibitor of NOX compared to apocynin (101, 181), it was assumed to have the same affect as 
apocynin on preventing the upregulation of GR activity following exercise. It is important to fully 
characterize the mechanism by which VAS2870 prevents the cardioprotective phenotype 
afforded by exercise. This may provide further insight into the “triggering” mechanisms of 
exercise cardioprotection, potentially leading to a new area of investigation. 
While these studies implicate redox control in cardioprotective models, it is imperative to 
further our knowledge on how redox biology affects mitochondrial function, and what 
mechanisms may be at play in mediating the protection afforded by preserved redox 
homeostasis. Chapter 3 sought to address the mechanistic link between preserved redox 
homeostasis and maintenance of electrical activity in the post-ischemic myocardium, however 
more research is needed to fully characterize how loss of ∆Ψm scales to affect electrical 
conductivity in the intact heart. It is presumed that maintenance of energetics preserves cellular 
ATP levels, where ATP-regulatory sites on energy sensitive ions channels then mediate the 
protective phenotype. However, these assumptions need to be substantiated in the intact 
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Appendix B: Figure reproduction 
 
  
Figure 1. Breakdown of deaths attributable to CVD in the United States (2013). 
46.20%  Coronary Heart Disease
16.10%  Stroke
8.10%  Heart Failure
9.00%  High Blood Pressure
3.20%  Diseases of the Arteries
17.40%  Other
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Figure 3. Reductions in infarct size are abolished by inhibiting NADPH Oxidase (with pre-exericse treatment 
of apocynin or VAS2870) during exercise. Inhibition of mitochondrial ROS during exercise (with pre-exercise 
administration of TEMPO or the mitochondria-targeting peptide Bendavia) had no effects on exercise 
 







Figure 4. Arrhythmia and simultaneous two-photon imaging of mitochondrial membrane potential (ΔΨm) 
in isolated hearts during ischemia/reperfusion. (A) The percentage of Ex and Sed hearts that transitioned to 
arrhythmia (VT/VF) following 40 min of ischemia. (B&C) Baseline TMRM fluorescence (ΔΨm) values were used to 
normalize all data (F/F0) during ischemia (B) and reperfusion (C). (D) Representative images of ΔΨm in the 
ventricular free-wall and simultaneous ECG recordings during reperfusion for Sed and Ex. Data are shown as % 
of population for arrhythmia and mean ± SEM for all other data, n=7-8 per group. * p<0.05 vs Sed; # p<0.05 vs 
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Figure 5. Mitochondrial membrane potential (ΔΨm) in isolated hearts that transitioned to arrhythmia vs 
no arrhythmia during reperfusion. (A) ΔΨm was was better maintained in hearts that did not transition to 
arrhythmia. (B) Mean ΔΨm fluorescence values during reperfusion. Data are mean ± SEM * p<0.05 vs 
Arrhythmia; # p<0.05 vs Arrhythmia main effect. 
 
   
111 
  
Figure 6. Cardiac glutathione (GSH) during cellular hypoxia/reoxygenation or cardiac 
ischemia/reperfusion. (A) Representative primary cardiac myocyte fluorescent images for Sed and Ex during 
baseline, at the end of hypoxia, and 6 minutes into reoxygenation. (B) Quantification of glutathione levels as 
measured by CellTracker Blue fluorescence. (C) HPLC quantification of reduced (GSH) and oxidized (GSSG) 
glutathione in hearts following ischemia/reperfusion. Data are shown as mean ± SEM, * p<0.05 vs Sed; # p<0.05. 
vs Sed main effect. 


















































































   




































Figure 7. Mitochondrial membrane potential (ΔΨm) during cardiac myocytes hypoxia/reoxygenation (H/R). 
(A) Representative images of Sed and Ex cardiac myocytes during H/R. Depolarized mitochondrial networks and 
collapses in ΔΨm are shown during reoxygenation as a transition in color from yellow to red and black. (B) 
Quantification of TMRM fluorescence during H/R. Data are shown as mean ± SEM. # p<0.05 vs Sed main effect. 
 





















































































































































TrxR inhibition GR inhibition
Figure 8. Reactive oxygen species (ROS) and isolated mitochondrial energetics during 
anoxia/reoxygenation (A/R). Sed is gray and Ex is black in all graphs.  O2 consumption rate (JO2) and H2O2 
emission rate (JH2O2) was measured in isolated mitochondria from Sed and Ex hearts. (A) JO2 was similar at 
baseline between Ex and Sed isolated mitochondria respiring on glutamate + malate, pyruvate, and succinate, 
and ADP clamped at 75 μM (state 3). (B) Impairments in state 3 JO2 following A/R was determined by 
comparing relative decreases from baseline for Sed and Ex. (C) State-3 JH2O2 before and after A/R. (D) The 
JH2O2:JO2 ratio demonstrates impaired mitochondrial function in Sed mitochondria following A/R. (E) A 
representative experiment showing a trace of resorufin fluorescence used to calculate JH2O2 during A/R. For 
clarity, data were transformed by subtracting the anoxic fluorescent value recorded prior to reoxygenation. (F) 
JH2O2 in isolated mitochondria in the presence of either thioredoxin reductase inhibitor (AF) or glutathione 
reductase inhibitor (BCNU).  Data are shown as mean ± SEM. * p<0.05 vs Sed main effect ; # p<0.05 vs Sed 
baseline. 
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Figure 9. Gsr knockdown and overexpression in H9c2 cells. (A) Western blot and densitometry after 48hr 
transfection with shRNA cloned into the pLKO.1 vector. (B) GFP and phase images 48hr post transfection. (C) 
Illustration of adenovirus expression cassettes of shgsr, shscram, Gsr overexpression (Gsr OE), and empty 
vector control (EV). (D) 96hr post infection fluorescent images of differentiated H9c2 cells, and (E) Western blot of 
glutathione reductase protein content. 
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Figure 10. Mitochondrial bioenergetic analysis in H9c2 cells exposed to 
hypoxia/reoxygenation. (A) Seahorse trace of mitochondrial stress test protocol following a 20min 2-
AAPA exposure. All data were transformed by subtracting out the antimycin A respiratory rate. (B) 
Basal respiration. (C) Maxmial uncoupled respiration with FCCP (E) ATP-dependent respiration 
(Basal respiration – State 4). Data in C-E are expressed as percent of Non-H/R control for each time 
point. *p<0.05 vs vector control. 
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Figure 11. Mitochondrial bioenergetic analysis in H9c2 cells following pharamacological induction of thiol 
redox stress. (A) Seahorse trace of mitochondrial stress test protocol following a 20min 2-AAPA exposure. All 
data were transformed by subtracting out the antimycin A respiratory rate. (B) Basal respiration. (C) Maxmial 
uncoupled respiration with FCCP (E) ATP-dependent respiration (Basal respiration – State 4). (F) Mitochondrial 
membrane ∆Ψm with TMRM and (G) cell viability following 2-AAPA exposures.*p<0.05 vs CTRL (ANOVA followed 
by Dunnett’s post-hoc test). 
 



















































































Figure 12. Infarct size and arrhythmia in isolated hearts following ischemia/reperfusion. (A) Infarct size for 
isolated rat hearts following 20 minutes of ischemia and 2 hours of reperfusion. (B) Arrhythmia score following the 
first 15 minutes of reperfusion. (C) The time to contracture was determined by calculating the amount of time 
elapsed during ischemia leading to a 5mmHg increase in end-diastolic pressure (EDP). All data are mean ± SEM, 
n=5-7 per group. * p<0.05 vs SD. 
 







































































































































































Figure 13. Mitochondrial function following ischemia/reperfusion injury. (A) O2 consumption rate (JO2) in 
isolated mitochondria under state 4 conditions (no ADP) with glutamate (10mM), malate (2mM), and pyruvate 
(5mM). (B) JO2 under state 3 conditions with saturating ADP (4mM). (C) Citrate synthase activity. (D) Relative 
specific activity of complex I normalized to the respective citrate synthase activity. (E) H2O2 emission rate (JH2O2) 
under state 4 conditions (same substrate as Figure 2A). (F) JH2O2 with saturating ADP. All data are mean ± SEM, 
n=4 per group, JO2 and JH2O2 assays were run in duplicate and kinetic assays were run in triplicate. * P<0.05 vs 
SD, # p<0.05 vs SV. 
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Figure 14. Mitochondrial membrane lipid properties and respiratory supercomplex assembly. (A) 
Merocyanine 540 (MC540) fluorescent spectra before and after the addition of mitochondria. Note the peak 
fluorescence red shift of the spectra indicates a lipid phase (B) Relative shift in MC540 fluorescence following the 
addition of mitochondria (F-F0). C) Peak fluorescence intensity at 600nm. D) Representative image of 
supercomplex density via Blue-native PAGE; n=4 per group run in duplicate. The black box encloses 
supercomplex I, III2, IV and used for quantification. E) Quantification of densitometry from supercomplex gel, 
normalized to control. All data are mean ± SEM, n=4 per group. 
